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resumo 
 
 
A importância crescente da aquacultura a nível mundial contribui para compensar a 
progressiva redução das populações naturais de peixe. Contudo, o facto de várias 
pisciculturas sofrerem, frequentemente, grandes perdas económicas, devido a 
infecções causadas por microrganismos patogénicos, incluindo bactérias 
multiresistentes, torna urgente o desenvolvimento de estratégias menos lesivas para o 
ambiente. A Terapia fágica surge como uma potencial e emergente alternativa ao uso 
de antibióticos e outros antimicrobianos. O principal objectivo deste trabalho consistiu 
na avaliação da eficácia da terapia fágica para inactivar bactérias patogénicas de 
peixes em pisciculturas de regime semi-intensivo, sendo que para isso foram 
efectuados diversos estudos prévios.  
A dinâmica sazonal das comunidades virais e bacterianas foi seguida em amostras de 
água da piscicultura Corte das Freiras, tendo-se identificando as principais bactérias 
patogénicas e avaliado o nível de contaminação fecal. O número total de vírus foi 
determinado por microscopia de epifluorescência e a abundância relativa das 
principais bactérias patogénicas determinada por FISH (Fluorescent in situ 
hibridization). A dinâmica sazonal da comunidade bacteriana foi avaliada por 16S 
rDNA DGGE (Denaturing Gradient Gel Electrophoresis). Uma vez que vibriosis e 
photobacteriosis representam duas das principais causas de mortalidade nos peixes em 
pisciculturas, a diversidade da comunidade bacteriana do género Vibrio também foi 
avaliada por DGGE. O nível de contaminação fecal foi avaliado através da 
quantificação do teor de coliformes fecais e de enterococos fecais, usando o método 
das membranas de filtração. Para o estudo da cinética da interacção bactéria-
bacteriófago usou-se a infecção cruzada. Para aplicar com sucesso a terapia fágica é 
importante ter informações sobre a sobrevivência dos fagos e o seu impacto ecológico 
na estrutura da comunidade bacteriana após adição dos fagos das principais bactérias 
patogénicas de peixe. Os resultados obtidos mostram que o número total de vírus na 
água da aquacultura é bastante elevado, variando entre 6.1 x 109 particulas L-1 e 1.0 
x1010 particulas L-1. O número total de bactérias permanece praticamente constante, 
contudo os grupos específicos de bactérias variam significativamente ao longo dos 
períodos de amostragem. No caso dos indicadores bacterianos, foi observada uma 
clara variação sazonal, com os níveis mais elevados de poluição fecal registados em 
Outubro de 2007 e os mais baixos registados em Maio 2009. A análise de fragmentos 
de 16S rDNA por DGGE sugere que a estrutura da comunidade bacteriana varia 
sazonalmente, verificado-se uma maior diversidade na estação mais quente. No caso 
do género Vibrio a análise por DGGE sugere também uma variação sazonal na 
comunidade bacteriana pertencente a este género, ainda que não tão evidente. Os
resultados de infecção cruzada sugerem que, com excepção do fago de Aeromonas 
salmonicida , os fagos inoculados nas principais bactérias patogénicas de peixe 
apresentam um largo espectro de infecção do hospedeiro. A sobrevivência dos fagos 
na água da aquacultura variou, sendo que o fago de Aeromonas salmonicida
sobreviveu aproximadamente 3 meses, enquanto o fago de Vibrio parahaemolyticus
sobreviveu cerca de 15 dias. A adição dos fagos à comunidade bacteriana não 
conduziu a uma variação significativa na estrutura da comunidade bacteriana. Em 
conclusão, como o teor de vírus e a sobrevivência dos fagos na água da aquacultura 
são elevados e a adição dos fagos específicos das bactérias patogénicos tem um baixo 
impacto ecológico na estrutura da comunidade bacteriana natural, a terapia fágica 
pode ser aplicada com sucesso na inactivação das bactérias patogénicas de peixes. 
Além disso, a infecção múltipla pelos fagos aumenta a capacidade de inactivação de 
bactérias patogénicas. No entanto, como a densidade e a estrutura das comunidades 
bacterianas totais e patogénicas varia sazonalmente, torna-se necessário ter este facto 
em consideração aquando da escolha dos fagos a utilizar para terapia fágica. 
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abstract 
 
Due to the increasing importance of aquaculture for the compensation of 
progressive worldwide reductions in natural fish stocks and to the fact that 
several fish farming plants often suffer from heavy financial losses due to the 
development of infections caused by microbial pathogens, including multidrug 
resistant bacteria, more environmentally-friendly strategies to control fish 
infections are urgently needed to make the aquaculture industry more 
sustainable. Phage therapy is an emerging and potential viable alternative to 
antibiotics and other antimicrobials. 
The main target of this work was to evaluate the use of phage therapy to 
inactive fish pathogenic bacteria in aquaculture systems, thus, several 
preliminary studies were developed. In this work the seasonal dynamics of viral 
and bacterial communities of the aquaculture system Corte das Freiras was 
followed, the main pathogenic bacteria were identified and the level of faecal 
contamination in the aquaculture was evaluated. The total number of viruses 
was determined by epifluorescence microscopy and the relative abundance of 
specific bacterial groups of was accessed by FISH (Fluorescent In Situ 
Hybridization). The seasonal dynamics of bacterial community structure was 
evaluated using 16S rDNA DGGE (Denaturing Gradient Gel Electrophoresis). 
As vibriosis and photobacteriosis represent two of the main causes of fish 
mortality in fish farms, the diversity of the fish pathogens belonging to the 
Vibrio genus was also assessed by DGGE. The level of faecal contamination 
was evaluated through the quantification of faecal coliforms and faecal 
enterococci, using the membrane filtration method. The kinetics of pathogenic 
bacteria-phages interaction was also studied in laboratory, using cross infection. 
In order to apply phage therapy successfully, it is important to know the 
survival of the phage and the ecological impact of phage therapy in the 
diversity of bacterial communities after the additions of phages of the main fish 
pathogenic bacteria. The results obtained show that the number of viruses in the 
aquaculture water was high, varying between 6.1 x 109 cells L-1 and 1.0 x1010 
cell L-1. The number total bacteria was almost constant over the year, but the 
specific bacterial groups varied significantly during the sampling period.A clear 
seasonal variation in bacterial indicators was observed, with the highest values 
of faecal bacteria occurring in October 2007 and the lowest in May 2009. The 
16S rDNA DGGE results showed that bacterial community structure varied 
seasonally, showing a higher diversity during the warm season. The diversity of 
the Vibrio genus also showed a seasonal variation, but not so clear. The cross 
infection results showed that, with the exception of Aeromonas salmonicida 
phage, the phages inoculated on the main fish pathogenic bacteria displayed a 
large spectrum of host infection. The survival of the phages was variable; the 
Aeromonas salmonicida phage survived in aquaculture water during 
approximatelly three months and the phage of Vibrio parahaemolyticus 
survived only during fifteen days. Phage addition to the bacterial community 
did not result in a significant variation in bacterial community structure. In 
conclusion, as the level of viruses and survival of these phages are high in 
water from the aquaculture system and the addition of specific phages of 
pathogenic bacteria has a low ecological impact on the structure of the natural 
bacterial community, suggests that phage therapy can be a successful approach 
to inactivate fish pathogenic bacteria. Moreover, the occurrence of multiple 
infections by these phages improve their potential to inactive fish pathogenic 
bacteria. However, as the density and structure of total and pathogenic bacterial 
communities varied seasonally, it is necessary to take in consideration this 
variation when specific phages are selected for phage therapy. 
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Chapter 1 – Introduction 
1.1 Bacteriophages 
1.1.1. Discovery of bacteriophages 
Since the discovery of phages by Frederick Twort in 1915 and independently in 1917 by 
Felix d’ Herelle, phages have become a relevant research field. D’ Herelle pioneered two 
important areas of phage research: he reported that bacteriophages have potential to kill bacteria 
that cause diseases in humans, plants or animals at early stages and developed phage therapeutic 
agents in the pre-antibiotic era (Sulakvelidze et al, 2001).  
With the recent development of antibiotic resistance within the microbial population, the 
need for new antibacterial and alternative strategies to control microbial infections has become 
an urgent necessity, leaving way for phage therapy to reborn as a valid option for treating 
bacterial infections. Lytic phage kill bacteria via mechanisms that differ from those of 
antibiotics, and therefore, can be considered as antibacterials with “novel mode of action”, a 
concept desired for all new antibacterial agents (Sulakvelidze et al, 2001). 
1.1.2. Properties of bacteriophages 
Based on the new viral classification system proposed by Raoult and Forterre (2001), a 
prokaryotic virus can be defined as a capsid-encoding organism that is composed by proteins 
and nucleic acids, self-assembles in a nucleocapsid that uses a ribosome-encoding prokaryotic 
organism for the completion of its life cycle (Raoult et al, 2008). The bacteriophages (phages) 
present a variety of different morphological types, but the majority displays a capsid, collar and 
tail (Figure 1.1). According to the latest phage counts, tailed phages comprise at least 4950 
viruses (Ackermann, 2000), polyhedral, filamentous and pleomorphic phages comprise only 
about 190 viruses (Ackermann, 2003). The head (or capsid) is a protein shell often in the shape 
of an icosahedron; it contains the viral genome that usually comprises a double-strand (ds) DNA 
molecule (Ackermann, 2003; Hanlon, 2007). Though most phages contain dsDNA, there are 
small phage groups with ssDNA, ssRNA, or dsRNA (Hanlon, 2007). The tail may have a 
contractile structure to which six tail fibres are usually connected. At the tips of the fibres, the 
presence of receptors allows the recognition of attachment sites on the bacterial cell surface. In 
phages that do not display tail or tail fibres, other attachment mechanisms are present (Hanlon, 
2003).  
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Figure 1.1: Diagrammatic representation of a typical bacteriophage (extracted from Hanlon, 2003). 
1.1.3. Classification of bacteriophages 
Bacteriophage taxonomy is based on their shape and size as well as on their nucleic acid 
(figure 1.2) (Ackermann, 2003). The ICTV or International Committee for Taxonomy of 
Viruses presently classifies viruses into three orders, 61 families, and 241 genera (M.H.V, 
2000). Bacteriophages constitute one order, 13 families and 30 genera (Table 1.1). 
Table 1.1: Basic properties of bacteriophages and their classification (Ackermann, 2003)  
Shape Nucleic acid Order and 
families 
Genera Examples Characteristics 
Tailed DNA, ds, L Caudovirales 15   
 
 Myoviridae 6 T4 Tail contractile 
 
 Siphoviridae 6 λ Tail long, noncontractile 
 
 Podoviridae 3 T7 Tail short 
Polyhedral DNA, ss, C Microviridae 4 φX174  
 
        ds, C, T Corticoviridae 1 PM2 Complex capsid, lipids 
 
         ds, L Tectiviridae 1 PRD1 Internal lipoprotein vescicle 
 
RNA, ss, L Leviviridae 2 MS2  
 
        ds, L, S Cystoviridae 1 φ6 Envelope, lipids 
Filamentous DNA, ss, C Inoviridae 2 fd Filaments of rods 
 
         ds, L Lipothrixviridae 1 TTV1 Envelope, lipids 
 
         ds, L Rudiviridae 1 SIRV1 Resembles TMV 
Pleomorphic DNA, ss, C, 
T 
Plasmaviridae 1 L2 Envelope, lipids, no capsid 
 
        ds, C, T Fuselloviridae 1 SSV1 Spindle, lipids, no capsid 
Legend: C, circular; L, linear; S, segmented; T, superhelical; 1, single-stranded; 2, double-stranded. 
As for the other viruses, phages families are chiefly defined by nature of nucleic acid and 
particle morphology. There are no universal criteria for genera and species. The ICTV uses 
every available property for classification and has adopted the “polythetic species concept”, 
meaning that a species is defined by a set of properties, some of which may be absent in a given 
member (M.H.V, 1990). Taxonomic names of orders, families, and genera are typically 
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constructed from Latin or Greek roots and end in -virales, -viridae, and -virus, respectively. 
Most icosahedric, filamentous, and pleomorphic phages have latinized names. So far, tailed 
phage genera have only vernacular names (e.g., “T4-like viruses”). 
 
Figure 1.2 - Schematic representation of major phage groups (extracted from Ackermann, 2003). 
1.1.4. The Phage Life Cycle 
Viruses can interact with their hosts in two major and distinctive ways, the lytic and 
lysogenic cycles of infection and more sporadically through pseudolysogeny (Figure 1.3) 
(Almeida et al, 2009). During the life cycle of a prokaryotic virus several phases common to all 
viruses can be identified: adsorption, separation of nucleic acids from protein coat, expression 
and replication of the nucleic acids, virion assembly, release and transmission (Duckworth, 
1987). 
 
 
Figure 1.3: General phage life cycle. The model is adopted from Weinbauer (2004) 
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In the life cycle of a typical lytic bacteriophage. the virus encounters its bacterial host during 
random motion and attaches via specific receptor sites (Figure 1.4) that may be any one of a 
wide variety of cell surface components, including protein, oligosaccharide, teichoic acid, 
peptidoglycan and lipopolysaccharide (Lenski, 1988; Hanlon, 2007). In some cases the 
attachment sites might be present on the cell capsule, flagella or even conjugative pili (Hanlon, 
2007). At start, the attachment is reversible but then becomes irreversible, being followed by 
transfer of phage genetic material into the host cell. Depending on the morphology of the virus, 
the phage genome can be injected into the bacterial cell using different mechanisms that often 
involve contraction of the tail and formation of a hole within the bacterial cell wall. The base of 
the phage DNA is chemically modified in order to protect itself from attacks by cellular 
restriction and nuclease enzymes. The viral genome is then transcribed by the host cell RNA 
polymerase, producing early mRNA that has the effect of taking over the metabolic machinery 
of the bacterium, redirecting its metabolic processes to the manufacture of new virus 
components. These components are then assembled into complete virions (Hanlon, 2007). 
After construction and assembly of new phage particles within the host cell, it remains the 
problem of their release in the environment. Almost all dsDNA phages develop enzymes that 
attack the bacterial peptidoglycan, such as lysozymes that target sugar bonds, endopeptidases 
that target peptide linkages or amidases that act on amide bonds (Fischetti, 2005). These lytic 
enzymes, usually termed muralytic enzymes or endolysins, are produced within the cytoplasm 
but require another enzyme to cross the cytoplasmic membrane before reaching their substrate. 
This enzyme is called a holin and it disrupts the membrane allowing the lysin to degrade the 
peptidoglycan (Young et al, 2000; Fischetti, 2005). Thus, the timing of cell lysis and release of 
phage progeny is controlled by the holin. Depending on their morphology, some phages are 
capable of escaping from the host cell without causing destruction of the host. These phages 
usually present a filamentous morphology and have no relevance in phage therapy. Between the 
adsorption phase and the lysing of the host cell and viral progeny release there is a period of 
time known as the latent period. 
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Figure 1.4: Lytic cycle of a bacteriophage (Hanlon, 2007). 
The lytic cycle is sometimes overcome, with phages integrating their DNA into the host cell 
DNA. The phages that display this behavior are called temperate phages and the bacterial cells 
are then termed lysogenic. While bacterial DNA replicates, the phage DNA replicates 
simultaneously, thus each daughter cell will contain the viral DNA (known as prophage). Cells 
may undergo several rounds of division but, occasionally, spontaneous lysis occurs, and 
progeny phage is released. External factors can also induce lysis of lysogenic cells such as 
treatment with mutagenic agents or exposure to ultraviolet light (Hanlon, 2007). Some 
temperate phages such as Mu can switch between lysogeny and lytic growth due to variation on 
of high temperature and stationary phase (Ranquet et al, 2005). The prophage directs the 
synthesis of a repressor protein that blocks the transcription of its own genes and also those of 
closely related bacteriophages (Hanlon, 2007). The presence of a prophage can therefore confer 
upon a bacterial cell some sort of immunity to infection by other phages. Lysogenic bacteria 
may possess other advantages in terms of the acquisition of genes conferring pathogenicity or 
increased virulence.  
When a prophage escapes regulation by the repressor, its DNA is cut free allowing it to 
engage in the lytic cycle. However, excision of prophage DNA is often imprecise and bacterial 
genes adjacent to the prophage DNA may be incorporated into the infectious phage DNA and 
then transferred to subsequent host cells. This process is known as transduction and is 
responsible for horizontal gene transfer, including those related to antibiotic resistance, from 
one bacterial cell to another (Hanlon, 2007). 
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The predominance of temperate phages on the marine environment is not clear, but 
Freifelder (1983) reported that more than 90% of known bacteriophages were temperate 
(Freifelder, 1983), while other authors (Ackermann, 1987; Jiang et al, 1994, Cochran et al, 
1998) suggested that only around 50% of bacterial strains contained inducible prophages. 
Temperate phages are not suitable candidates for phage therapy since they may not immediately 
destroy bacteria.  
Pseudolysogeny, also known as false lysogeny is described as a phenomenon where there is 
a constant production of phage in the presence of high host cell abundance (Ackermann, 1987). 
In this situation the phage lysis does not result in total host death and the abundance of phage 
remains in a state where he coexists with exponential host growth. Thus, in pseudolysogenic 
infection, bacteriophage can either proceed with lytic infection or enter a dormant intracellular 
phase (Wommack et al, 2000), in which case the phage genome does not integrate into host 
cellular replicons. Under these conditions, host cells do not provide enough energy in order for 
phages to enter in a true lysogenic or lytic condition. 
1.1.5. Bacteriophages in the marine environment 
The world of bacteriophages is currently in a period of renaissance due to new capabilities in 
metagenomic sequencing and due to the isolation of diverse novel virus-host systems. The 
reawakening of interest in prokaryotic viruses began in the mid 1990s as a consequence of their 
extraordinary abundance, namely in the marine environment and of the unchallenged acceptance 
of the fact that viruses represent the greatest pool of genetic diversity in the planet (Angly et al, 
2006; Culley et al, 2006; Allen et al, 2008) Viruses are the simplest life forms in aquatic 
systems, yet they play a crucial role in the regulation aquatic processes. Their enormous 
abundance (1010 -1011 particles L-1) (Almeida et al, 2001; Weinbauer, 2004; Suttle, 2007) and 
seemingly infinite diversity provides the vital clues to the true function of viruses.  
Most of marine viruses are bacteriophages that kill bacteria (Weinbauer, 2004) playing a 
significant role on the bacterial communities (Suttle, 2007).  
Viral lysis in aquatic systems removes 20-40 % of the bacterial standing stocks each day 
(Suttle, 1994) and can be as effective as grazing by protist to destroy bacteria (Almeida et al, 
2001; Weinbauer, 2004; Suttle, 2005). Consequently, viral lysis has an importante role on the 
biogeochemical cycles (Bergh et al, 1989; Fuhrman, 1999) .Moreover, as virus are host specific, 
they influence bacterial composition of aquatic communities (Almeida et al, 2001)  
Bacteriophages in the marine environment contain dsDNA genome (Weinbauer, 2004) and 
belong mainly to the Caudoviridales order (about 96%) and to the families Myoviridae, 
Siphoviridae and Podoviridae (Yoshida et al, 2006). The metagenomic analysis confirmed the 
dominance of dsDNA tailed phages in marine viral communities (Breitbart et al, 2002; Breitbart 
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et al, 2003; Breitbart et al, 2004). The same study also showed that a large number of sequences 
(6% of the total) corresponded to ssDNA phages belonging to Microviridae family (Angly et al, 
2006), a previously overlooked group, due to exclusion of ssDNA viruses by amplification and 
cloning procedures. RNA phages are also present in the marine environment (Alcântara et al, 
1995; Dore et al, 2000; Griffin et al, 2000) but in a recent metagenomic analysis of coastal 
waters no RNA phages were detected (Culley et al, 2006). However, the marine environment 
has been shown to be a reservoir of previously unknown RNA viruses, with 98% of RNA 
viruses belonging to positive-sense ssRNA viruses (Culley et al,2006) and the predominant 
hosts of marine RNA viruses being eukaryotes (Almeida et al.,2009).  
1.2 Aquaculture 
Aquaculture of aquatic animals and plants culture (Pillay et al, 2005). Usually, aquacultures 
are located in offshore areas where is salmon and trout are usually grown or in coastal or inland 
waters where a variety of fish such as catfish, yellowtail, tilapia and seabream are raised. 
Aquaculture system that are fully enclosed or have recirculating mechanisms have the 
advantage of being land based and not having to be in close proximity to the sea, avoiding 
infections caused by wasteborn diseases (Sapkota et al, 2008). 
Aquaculture provides nearly one-third of the world’s seafood supplies and is one of the 
fastest growing agricultural sector (Almeida et al, 2009). The high increase on aquaculture 
production makes this sector the sector even more attractive. The annual production has tripled 
during the last 15 years, from 16.8 million tons in 1990 to 52.9 million tons in 2005 (Figure 1.5) 
(FAO and Fishery Information Data and Statistics Unit, 2005). This behavior is predicted to 
continue, with total annual global fish production (wild and farmed) expected to increase 
steadily, from 129 million tons in 2000 to 172 million tons by 2015, accounting aquaculture for 
as much as 73% of the total increase (Sapkota et al, 2008) 
A potential problem to this expansion is that aquacultures often suffer from heavy financial 
losses (Flegel et al, 2006; Saksida et al, 2006), due to the development of infections caused by 
microbial pathogens, including multidrug resistant bacteria that are easily transmitted through 
water and therefore able to infect a great variety of fish species. Thus, new approaches, as 
phages therapy, to reduce the impact of infections are welcome. 
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Figure 1.5 - Global trends in annual seafood production, 1950–2003 (FAO, 2005). 
1.2.1. Fish Farming Diseases 
Although there are many biological agents like bacteria, viruses, protists and helminths, 
oomycetes and fungi that threaten cultured fishes, bacterial diseases represent the main problem 
in the expansion of aquaculture industry (Alderma et al, 1996; Shao, 2001; Wahli et al, 2002). 
Two broad groups of bacteria of public health significance infect culture fish: those naturally 
present in the environment - the indigenous microflora (e.g., Photobacterium damselae, Vibrio 
anguillarum, V. vulnificus, Aeromonas hydrophila, Aeromonas. salmonicida) and those 
introduced through environmental contamination by domestic animals and/or human wastes – 
non-indigenous microflora (e.g., Enterobactereaceae such as Salmonella sp. and Escherichia 
coli) (Muroga et al, 1987; Huss, 1994; Fukuda et al, 1996; Iida et al, 1997, Nakai et al, 1999; 
Nakai et al, 2002). Although a great number of pathogenic bacteria die in environmental water, 
a high number of these remain on the skin and in the guts of fish and can cause a health risk to 
consumers. Vibriosis and photobacteriosis (formerly pasteurellosis) are the main diseases of 
marine and estuarine fish, both in natural and commercial production systems throughout the 
world, occurring only occasionally in freshwater fish. These diseases can cause significant 
mortality in fish that might ultimately lead to total death in infected facilities, becoming 
responsible for the most outbreaks of fish farming plants. The vibriosis and photobacteriosis are 
caused by bacteria of the same family, the Vibrionaceae. Vibrosis is caused by species of 
Photobacterium (namely Photobacterium damselae subsp. damselae, formerly Vibrio 
damselae) and Vibrio (namely V. anguillarum, V. vulnificus, V. alfinolyticus, V. 
parahaemolyticus and V. salmonicida) ewhile photobacteriosis is caused by P. damselae subsp. 
piscicida (formerly Pasteurella piscicida), an highly pathogenic bacteria that does not seem to 
have host specificity, infecting potentially an ample range of fish species (Toranzo et al, 1991;. 
Noya et al,1995) This pathogen was responsible for high mortality rates in cultured populations 
of seabass (Dicentrarchus labrax) and seabream (Sparus aurata) on several countries from the 
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Mediterranean area such as France, Italy, Spain, Greece, Portugal, Turkey, Malta, Israel and 
Croatia (Thyssen et al, 2001). Nowadays, photobacteriosis continues to be a severe problem in 
intensive cultures of different fish species in the Mediterranean area and in Japan. Vibrionaceae 
species are also known to cause disease in humans, most often following the consumption of 
contaminated aquaculture products. Other bacteria as Rickettria (Fryer et al, 1996), Aeromonas 
salmonicida (Bernoth et al, 1997), Edwardsiella tarda (Nakatsugawa et al, 1983; Mekuchi et al, 
1995), Cytophaga marina (formerly Flexibacter maritimus) (Kusuda et al, 1982; Wakabayashi 
et al, 1984), Flexibacter sp (Hamaguchi et al, 1993) , Flavobacterium psychrophilum and 
Pseudomonas plecoglossicida are also important fish pathogens, some of them capable of 
infecting a wide range of fish (Park et al, 2000). 
Viruses infection also cause heavy losses in aquaculture industry (Munn, 2006; Saksida et al, 
2006), but the risk of human infection due to fish consumption is low because viruses causing 
fish disease are not pathogenic to humans (Almeida et al, 2009). Viruses infecting commercial 
fish have been intensively studied and have been shown to encompass a wide range of viral 
families, including Irodovirus, Rhabdovirus, Birnavirus, Nodavirus, Reovirus, and 
Herpesviruses (Muroga, 2001; Suttle, 2007). An important fact is that some of these viruses 
present broad host ranges and seem to circulate between marine and freshwaters, making the 
transmission of the virus to new areas a serious threat (Meyers et al, 1999; Skall et al, 2005). 
A few helminth species also represent a concern in the aquaculture industry (WHO, 1995) 
causing diseases as trematodiasis, cestodiasis and nematodiasis, but also create conditions for 
bacterial infections to start (WHO, 1995). Infections by aquatic Oomycetes are considered the 
second cause of infection, after bacteria, namely in freshwater systems (Ogbonna et al, 1991; 
Gieseker et al, 2006). 
Farmed fish live in a potential unfavorable environment, which can explain the high 
incidence of diseases in aquaculture plants. Relatively to wild ones, the great density they live in 
can enhance the transference of pathogens between individuals (Almeida et al, 2009). Other 
factors such as overfeeding, high temperature and fast growth to cultivate fish as soon as 
possible in fish farming plants also contribute to higher disease rates (Almeida et al, 2009). The 
presence of sick, moribund and dead fish in closed waters also increases the risk of pathogens 
transference because they are only removed with higher water renewal rates (Weiss, 2002). 
1.2.2 Preventive Measures in Fish Farming Plants 
Preventing the occurrence of aquaculture diseases is the ideal way and the most cost-
effective measure in aquaculture. The success of prevention is always dependent on diverse 
variables, specially the fish farming conditions and feed quality that can lead to the need of 
using effective biocontrol techniques to reduce infections (Almeida et al, 2009). Other factors 
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can also accentuate the problem, includinglow microbiological quality of aquaculture waters 
(high levels of faecal indicators of water quality) (Huss ,1994 Howgate et al, 1997;Almeida et 
al,2009); low stability of environmental conditions (e.g., increased temperatures, salinity 
changes, oxygen depletion, high organic loads) that can lead to the expansion of the disease, 
often by weakening the innate defense systems of the fish (Defoirdt et al, 2007); high densities 
of fish stocks, which can induce disease transference, decreasing the resistance to infection 
(Defoirdt et al, 2006); the different stages of the fish life cycle are susceptible to 
infections (Alderman,1999); increasing problems with resistance against antibiotics in 
common pathogenic bacteria and the concern about spreading of antibiotics in the 
environment (Defoirdt et al, 2006); low efficiency of chemotherapeutic agents that are 
effective against bacteria and oomycetes against endospores and zoospores (Alderman,1999); 
and the fact that few drugs are licensed for fisheries use (Kusuda et al, 1998; Muroga, 2001). 
Vaccination 
Following the idea of prevention, vaccination would be the ideal method to prevent 
infectious diseases, but commercially available vaccines are still very limited in the aquaculture 
field (Reed et al, 1996; Romalde et al, 2002; Arijo et al, 2005). 
Vibrosis and pasteurelosis have been already controlled to a great extent through the use of 
vaccines (Press et al, 1995; Reed et al, 1996; Romalde et al, 2002; Arijo et al, 2005). A vaccine 
against the Vibrio spp. has proven to be effective especially when administered by injection in 
European Salmonid aquaculture. Photobacterium damsela piscicida was controlled with a 
survival rate of 75% when applying a toxoid-enriched whole-cell vaccine to fish with 0.5-2.0 g. 
Another successful attempt was the prophylactic immunization for other bacterial diseases of 
farmed fish, namely against Aeromonas salmonicida and Yersinia ruckeri (Press et al, 1995). 
However, there are still no commercially available vaccines against two other important 
bacterial fish diseases: bacterial kidney disease and rickettsial septicaemia. The nature of the 
immunity acquired by fish through vaccination has not yet been clarified, namely in the cure of 
fish at larval age (Reed et al, 1996). Other problem is the impossibility of vaccinating fish 
larvae that are the most susceptible to infection, due to their small size and to the fact that they 
do not develop specific immunity (Vadstein, 1997). 
The development of vaccines for fish viral diseases is even more difficult than for bacterial 
diseases. The unsuccess is due to killed virus residual virulence in the target species, virulence 
for other fish species, persistence in the treated fish and the fear that the virus might revert to 
virulence (Almeida et al, 2009).  
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Similar to what occurs with bacteria, the difficulty in developing anti-viral vaccines is due to 
the fact that these diseases occur primarily at the fish fry age and it is difficult to inject these 
small animals (Almeida et al, 2009). Until now, only a recombinant DNA based vaccine for 
infectious pancreatic necrosis virus was approved (Christie et al, 1997). 
Chemotherapy  
Although the chemotherapy has been shown to be a rapid and effective method to treat or 
prevent infections, the more frequently used chemotherapeutic agents are often responsible for 
the development of drug resistant microbial strains (Almeida et al, 2009).  
The recursive and massive use of antibiotics in aquaculture systems, in order to prevent the 
spread of disease, has contributed to the development of resistant strains on bacteria. As a 
consequence, antibiotics are frequently not effective in disease treatments. A possible reason 
might be the fast replication of microorganisms that can induce quick mutations that become 
predominant on the microbial population, helping the microbe to survive even in the presence of 
antibiotics (Almeida et al, 2009). In fact, in marine environment more than 90% of bacterial 
strains are resistant to more than one antibiotic and 20% are resistant to five, at least (Martinez, 
2003). 
Besides antibiotic treatment can became ineffective, the excessive use of this kind of 
treatment can become a serial threat to human and environment health (Alderman, 1996; Nakai 
et al, 1999). It has been showed that antibiotic resistances that have emerged and/or evolved in 
the aquaculture environments can be transmitted by horizontal gene transfer to bacteria of the 
terrestrial environment, including animal and human pathogens. This fact can bring alterations 
to the normal human gut microflora and generate problems like allergy and toxicity (Cabello, 
2006). 
This massive use of antibiotics in the aquatic field, especially in fish farms has been detected 
around the world (Almeida et al, 2009). Holmstrom et al (2003) reported that in 76 shrimp 
farmers interviewed in Thailand, 56 used antibiotics. 
In Malasia, a study on retail fish showed that Aeromonas sp. isolated from fish were resistant 
to three or more antibiotics (Radu et al, 2003). In the Philippines, oxytetracycline, oxolinic acid, 
chloramphenicol, furazolidine, nitrofurans, erythromycin and sulfa drugs are commonly used to 
treat bacterial diseases (Nakai et al, 2002). Chemotherapy is also widely practiced in South 
America and Europe where only a limited number of legislated antibiotics are allowed, such as 
amoxacillin, ampicillin, chloramphenicol, erythromycin, florfenicol, flumequine, oxolinic acid, 
oxytetracycline, nitrofurazone, sulphadiazine-trimethoprim and tetracycline (Toranzo et al, 
1991; Bakopoulos et al, 1995; Sano, 1998). The small number of legislated antibiotics allowed 
is explained by the emergence of antibiotic resistant pathogens that have resulted in banning or 
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restriction of some kinds of antibiotics. This situation implies the development of alternative 
approaches to antibiotics to control bacterial pathogens. 
Other biocides such as malachite green and formaldehyde are also extensively used in 
aquaculture industry to treat protozoal and fungal infections. Malachite green is a triarylmethane 
dye that is highly effective against important protozoal and fungal infections (Hoffman et 
al,1974; Alderman,1985; Schnick, 1988), but it is well known that malachite green is 
environmentally persistent and produces a wide range of acute toxic effects on various fish 
species and certain mammals (Srivastava et al, 2004) The risks that this biocide brings to the 
consumers of treated fish (Alderman et al,1993) are enormous and includes effects on the 
immune, respiratory and reproductive systems due to its genotoxic, carcinogenic and mutagenic 
properties (Srivastava et al, 2004). Despite the use of this dye has been banned in 2002 in 
several countries, but is still being used in countries with lack of legislation (Almeida et al, 
2009). 
Other biocide used as disinfectant for prophylaxis of fish eggs and in first stages of larval 
development of fish is formaldehyde (Gieseker et al, 2006; Khodabande et al, 2006). Some 
successful studies were made using sodium chloride, formalin and iodine on carp eggs, leading 
to smaller mortality in infected adult fish (Gieseker et al, 2006; Khodabande et al, 2006). The 
main problem of this compound is the significant environmental impact and the carcinogenic 
risk to mammals, causing harmful effects on human health (Gieseker et al, 2006). Like 
formaldehyde and other antibiotics, its use is discouraged, limited or even banned in several 
countries (Magaraggia et al, 2006). 
In this way, to reduce the risk of development and spreading of microbial resistances and to 
control fish diseases in aquaculture, alternative strategies must be developed to allow the use of 
reasonably cost effective and more environmentally friendly methods. 
 
1.3. Phage Therapy: an Alternative to Antibiotics 
As bacterial diseases are the major problem in the expanding aquaculture, phage therapy 
represents a potentially viable alternative to antibiotics and to other antibacterial compounds to 
inactivate indigenous and non-indigenous pathogenic bacteria in fish farming plants (Almeida et 
al, 2009). 
1.3.1 Advantages of Phage Therapy over Chemotherapy 
When comparing phage therapy to chemotherapy, there are a great number of advantages on 
using phage therapy instead of chemotherapeutic agents on the environment. (1) Phages have 
 Chapter 1 | Introduction 
 
 
Page | 13 
specific target, that is, they are specific to a single species or even strain of bacteria, causing 
much less damage to the normal intestinal fish flora and to natural non-target bacteria. (2) The 
use of phages limits the development of resistance on bacteria, especially due to their higher 
mutation and replication rate when compared to antibiotics. The fact that phage co-evolves with 
their host bacteria also makes the discovery of new phages easier than developing new 
antibiotics Thus, even if bacteria acquire phage resistance, new mutant phage that acts lytically 
can be used against such bacteria (Matsuzaki et al, 2003). Other possibility to avoid the 
emergence of resistance strains during phage treatment is to prepare a mixture of different 
strains of phages. (3) Limited impact, unlike antibiotics, phages are self-replicating as well as 
self-limiting. They replicate exponentially as bacteria and decline when bacteria number 
decreases. Depending of the form of application, a single dose may be sufficient. (4) Regulatory 
approval, since phages are naturally occurring and very abundant, there may be substantially 
fewer problems involved in obtained regulatory approval for their use. (5) Environmental 
resistance; phages have contact with its pathogens on its natural arrangement, being 
permanently in contact with their hosts. (6) Efficient technology; the use of new therapies based 
on phages lead to a more flexible, fast and inexpensive technology than other that use 
antibiotics.  
1.3.2. Phage Therapy and Its Clinical Applications 
Before the development and massive use of antibiotics, it was suggested that bacterial 
infections could be prevented and/or be dealt with the administration of phages. At the 
beginning of 20th century, some studies involving human beings and animals were made, 
culminating in 1940 with the development of phage preparations by the Eli Lilly Company, in 
order to treat illnesses caused for example by Staphylococcus, Streptococcus, Escherichia and 
other pathogenic bacteria (Sulakvelidze et al,2001). But just after phage discovery, d'Herelle 
used phages to treat dysentery, in what was probably the first attempt to use bacteriophages 
therapeutically (Sulakvelidze et al, 2001). In this particular case, the phage preparation was 
ingested by d'Herelle and other hospital interns to test its effects before administering it in the 
next day to a 12-year-old boy with severe dysentery (Sulakvelidze et al, 2001). This first 
therapeutic use of bacteriophages ended successfully with the boy recovering in a few days after 
a single administration of d'Herelle's anti-dysentery phage. This preparation continued to be 
efficiently applied to patients. 
Despite these practical studies, the first reported and published application of phages to treat 
infectious diseases on humans came in 1921 from Richard Bruynoghe and Joseph Maisin 
(Bruynoghe et al, 1921). In this particular case, bacteriophages were used to treat 
staphylococcal skin disease, being applied into and around surgically opened lesions, with the 
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infection ceasing within 24 to 48 hours. With other promising studies of phage therapy applied 
to medicine (Rice, 1930; Schless, 1932; Stout, 1933), and the continuous research by d'Herelle, 
that treated thousands of people having cholera and/or bubonic plague in India (Summers, 
1999), several companies began active commercial production of phages against various 
bacterial pathogens. 
The majority of studies demonstrating the efficacy of phage therapy in clinical settings 
came from research groups in Eastern Europe and the former Soviet Union and were published 
in non-English journals (Sulakvelidze et al, 2001). Some of the reported work is decribed in 
Table 1.2, where phages were applied on different kind of infections including the treatment of 
cerebrospinal meningitis in a newborn (Stroj et al, 1999), skin infections caused by 
Pseudomonas, Staphylococcus, Klebsiella, Proteus, and E. coli (Cislo et al, 1987), recurrent 
subphrenic and subhepatic abscesses (Kwarcinski et al, 1994). 
More recently, studies with mice and farm animals by Smith et al. (1977) showed that 
phages could be used for both treatment and prophylaxis against bacterial infection (Smith et al, 
1997). The success of these studies led to an increased interest of phage therapy applications, 
especially in the West where researchers have been studying the effect of phages on antibiotic-
resistant bacteria capable of causing human infections. Other experiences with mice and guinea 
pigs reported the utility of phages in preventing and treating experimental disease caused by 
Pseudomonas aeruginosa and Acinetobacter infections. Soothill (1992, 1994) demonstrating no 
histological changes after administration of phage preparation. Infections caused by Klebsiella 
ozaenae, Klebsiella rhinoscleromatis scleromatis and Klebsiella pneumonia have also been 
successfully treated using bacteriophages (Soothill, 1992; Soothill, 1994). 
Phase I/II clinical trials with human patients are currently being conducted and by 2011 it 
can reasonably be envisioned that phage treatments would be into phase III or in clinical use 
(Comeau et al, 2008). 
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Table 1.2: Clinical applications of Phage Therapy in Poland and Soviet Union. ( Sulakvelidze et al, 
2001)  
References Infections Etiologic agents Comments 
Babalova et al. Bacterial dysentery Shigella Shigella phages were successfully used for prophylaxis of bacterial dysentery. 
Bogovazova et al 
(1968) 
Infections of skin and 
nasal mucosa 
K. ozaenae, K.  
hinoscleromatis, and 
K. pneumoniae 
Adapted phages were reported to be effective in treating 
Klebsiella infections in all of the 109 patients. 
Cislo et al. 
(1992) 
Suppurative skin 
infections 
Pseudomonas, 
Staphylococcus, Klebsiella, 
Proteus, and E. coli 
Thirty-one patients having chronically infected skin ulcers 
were treated orally and locally with phages. The success rate 
was 74%. 
Ioseliani et al. 
(1987) 
Lung and pleural  
infections 
Staphylococcus, 
Streptococcus, E. coli, 
and Proteus 
Phages were successfully used together with antibiotics to 
treat lung and pleural infections in 45 patients. 
Kochetkova et 
al.(1980) 
Postoperative wound 
infections in cancer 
patients 
Staphylococcus and 
Pseudomonas 
A total of 131 cancer patients having postsurgical wound 
infections participated in the study. Of these, 65 patients 
received phages and the rest 
received antibiotics. Phage treatment was successful in 82% 
of the cases, and antibiotic treatment was successful in 61% 
of the cases. 
Kucharewicz-
Krukowska 
and Slopek 
(1989) 
Various infections 
Staphylococcus, Klebsiella, 
E. coli, 
Pseudomonas, and Proteus 
Immunogenicity of therapeutic phages was analyzed in 57 
patients. The authors concluded that the phages 
immunogenicity did not impede therapy. 
Kwarcinski et 
al.(1994) 
Recurrent subphrenic 
abscess E. coli 
Recurrent subphrenic abscess (after stomach resection) 
caused by an antibiotic-resistant strain of E. coli was 
successfully treated with phages. 
Litvinova et al. 
(1978) 
Intestinal 
dysbacteriosis E. coli and Proteus 
Phages were successfully used together with bifidobacteria 
to treat antibiotic-associated dysbacteriosis in 500 low-birth-
weight infants. 
Meladze et al. 
(1982) 
Lung and pleural 
infections Staphylococcus 
Phages were used to treat 223 patients having lung and 
pleural infections, and the results were compared to 117 
cases where antibiotics were used. Full recovery was 
observed in 82% of the patients in the phage-treated group, 
as opposed to 64% of the patients in the antibiotic- treated 
group. 
Miliutina and 
Vorotyntseva 
(1993) 
Bacterial dysentery and 
salmonellosis Shigella and Salmonella 
The effectiveness of treating salmonellosis using phages and 
a combination of phages and antibiotics was examined. The 
combination of phages and antibiotics was reported to be 
effective in treating cases where antibiotics alone were 
ineffective. 
Perepanova et 
al.(1995) 
Inflammatory urologic 
diseases 
Staphylococcus, E. coli, 
and Proteus 
Adapted phages were used to treat acute and chronic 
urogenital inflammation in 46 patients. The efficacy of 
phage treatment was 92% (marked clinical improvements) 
and 84%  bacteriological clearance) 
Sakandelidze 
and Meipariani 
(1974) 
Peritonitis, 
osteomyelitis, lung 
abscesses, and 
postsurgical wound 
infections 
Staphylococcus, 
Streptococcus, and 
Proteus 
Phages administered subcutaneously or through surgical 
drains in 236 patients having antibiotic-resistant infections 
eliminated the infections in 92% of the patients. 
Sakandelidze 
(1991) 
Infectious allergoses 
(rhinitis, pharyngitis, 
dermatitis, and 
conjunctivitis) 
Staphylococcus, 
Streptococcus, E. coli, 
Proteus, enterococci, and 
P. aeruginosa 
A total of 1,380 patients having infectious allergoses were 
treated with phages (360 patients), antibiotics (404 patients), 
or a combination of phages and antibiotics (576 patients). 
Clinical improvement was observed in 86, 48 and 83% of the 
cases, respectively. 
Slopek et 
al.(1983) 
Gastrointestinal tract, 
skin, head, and neck 
infections 
Staphylococcus, 
Pseudomonas, E. coli, 
Klebsiella, and Salmonella 
A total of 550 patients were treated with phages. The overall 
success rate of phage treatment was 92%. 
Stroj et al. 
(1999) 
Cerebrospinal 
meningitis K. pneumoniae 
Orally administered phages were used successfully 
to treat meningitis in a newborn (after antibiotic therapy 
failed). 
Tolkacheva et al. 
(1981) Bacterial dysentery E. coli and Proteus 
Phages were used together with bifidobacteria to treat 
bacterial dysentery in 59 immunosuppressed leukemia 
patients. The superiority of treatment with phage-
bifidobacteria over antibiotics was reported. 
Weber-
Dabrowska 
et al (1987). 
Suppurative infections Suppurative infections 
Orally administered phages were used to successfully treat 
56 patients, and the phages were found to reach the patients’ 
blood and urine. 
Zhukov-
Verezhnikov 
et al (1978). 
Suppurative surgical 
infections 
Staphylococcus, 
Streptococcus, E. coli, 
and Proteus 
The superiority of adapted phages (phages selected 
against bacterial strains isolated from individual patients) 
over commercial phage preparations was reported in treating 
60 patients having suppurative infections. 
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1.3.3. Phage Therapy and Its Fish Farm Application 
Phage therapy is currently being applied all over the world in several investigation studies 
and for various usages, including the utilization of bacteriophages on wastewaters treatment and 
as biocontrol agents in food (Leverentz et al, 2001; Goode et al., 2003; Huff et al, 2005), plants 
(Flaherty et al, 2000), and cyanobacterial blooms. On the other hand, on the aquaculture field, 
studies using phages were made with the main purpose of identifying the specific 
bacteriophages to use in bacterial typing schemes and to characterize the bacteriophages 
properties, including their potential role in virulence. It is, however, commonly accepted that 
phage therapy can be applied as a preventive measure on fish farms, but few attempts have been 
made to use phages towards preventing bacterial infections in fish (Nakai et al, 1999; Park et 
al,2000; Park et al, 2003) The results of these few studies using phages specific to Lactococcus 
garvieae and to P . plecoglossicida, pathogens of yellowtail and of ayu (Plecoglossus altivelis), 
respectively, suggest that phages could be useful for controlling bacterial infections of fish 
(Nakai et al, 1999; Park et al,2000; Nakai et al, 2002; Park et al, 2003). 
Nakai et al. (1999) describes the in vivo survival of L. garvieae bacteriophages and the 
potential of the phage for controlling experimental L. garvieae infection in yellowtail (Nakai et 
al, 1999). On this experiment phages were administered by injecting phage infected cells into 
the spleen or intestine and also by phage-impregnated food. The results showed a high survival 
rate on phage-injected fish after challenge with L. garvieae (survival rate 100% of 20 
yellowtail), when compared to uninjected fish (survival rate 10% of 20 yellowtail). 
Simultaneous administration of live L. garvieae and phage enhanced the recovery of the phage 
from the fish organs. Protection was also obtained in yellowtail receiving phage-impregnated 
feed. Another interesting result showed that orally administered phage was detected at high 
plaque-forming units from the intestines and spleens of the phage-treated fish until 48 hours 
after administration. This study demonstrated that fish infection with L. garvieae can be 
prevented by administrating anti-L. garvieae phage, proving the utility of phages to control this 
kind of disease. The use of bacterial cells as a protector or vehicle did not influence the curative 
effect of phage. In other experiments, Nakai used two types of bacteriophages specific to P. 
plecoglossicida, the causative agent of bacterial hemorrhagic ascites disease in these fish 
species (Park et al, 2000). Diseased fishes showed the presence of infected cells on its kidneys 
during all experiment time, while fish that were oral administrated with P. plecoglossicida 
phage showed lower mortality rates (22.5% vs. 60%). These results indicate that orally 
administered phage can be expected to kill bacterial cells in internal organs, as well as bacterial 
cells in the intestine, which means that phage therapy can be effective at the systemic infection 
stage. Another interesting observation was the obtainance of phage isolates that were P. 
plecoglossicida-specific but not strain specific, which suggests that a single phage strain or a 
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few phage strains could provide effective phage therapy. The fish infection was obtained via 
oral route, suggesting that the intestine is an important portal of entry for the pathogen, and the 
narrow host range of phage should be an advantage in phage treatment because the phage does 
not harm the normal intestinal microflora (Nakai et al, 1999). 
In other experiments with the ayu fish, a combination of the previously isolated phage 
together with specific phage against P. plecoglossicida. The mortality rate of fish that received 
one of the phages varied from 53.3 to 40.0%, decreasing to 20.0% when the mixture of the two 
phages was used, increasing to 93.3% in the control fish receiving no phages, demonstrating the 
therapeutic effect of phages in natural infections (Park et al, 2003). In a field trial, when phage-
impregnated feed was administered to ayu in a pond, where the disease occurred naturally (fish 
mortality about 10 Kg d-1;ca. n=900 d-1), fish daily mortality decreased at a constant level (5 % 
per day) from days 3 to 15, reaching a steady state at about 6 Kg mortality d-1 (ca. n=300 d-1) 
thereafter, corresponding to a one-third reduction in relation to natural conditions. The fact that 
no phage-resistant organisms or phage-neutralizing antibodies were detected on the fish treated 
with phages proved the success of phage therapy treatment (Park et al, 2003). 
Additional studies have been conducted to demonstrate the efficacy of bacteriophage 
combination has a preventive measure on fish farms (Imbeault et al; 2006). Imbeault et al. 
(2006) studied the interaction between A. salmonicida and a bacteriophage to treat furunculosis 
in brook trout (Salvelinus fontinalis). The results obtained showed that more than one phage 
could infect A. salmonicida and that mutants resistant to one phage were sensitive to other 
phages. Resistant bacteria had a shorter generation time than the original strain and the success 
of their replating was very low. After the first plating, more than 25% of the mutants seemed to 
revert to the original strain phenotype and the totality was sensitive to three or more phages.  
Besides some successful results, other experiments have not shown the same behavior on 
fish when applying phage therapy. The attempt to control furunculosis of Atlantic salmon 
(Salmo salar) caused by A. salmonicida showed that fishes injected with bacteriophages 
immediately after challenge, died at a significant slower rate than those that were not treated 
with phages (Verner-Jeffreys et al, 2007). Phage treatment 24 hours after the challenge resulted 
in a mortality rate similar to the rate observed in un-treated fish. The results for Atlantic salmon 
were not as good as other described before, but the fact that there were no safety problems 
associated with the approach must also be highlight.  
More recently, Walakira et al. (2008) isolated two lytic bacteriophages specific for 
Edwardsiella ictaluri that cause enteric septicemia of catfish (Walakira et al, 2008). Each E. 
ictaluri strain tested was susceptible to phage infection with variable efficiencies but with no 
evidence of lysogeny and with no plaques detected on other bacterial species, demonstrating 
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their potential use as biotherapeutic and diagnostic agents associated with enteric septicemia of 
catfish. 
Studies using bacteria that infect fish farm plants and can also be responsible for serious 
infections on humans were recently reported. This group includes bacteria of the Vibrio family 
such as Vibrio campbelli, V. parahaemolyticus, Vibrio cholerae, V. vulnificus and the 
luminescent Vibrio harveyi. A host range of seven phages from hatchery and creek water of 
aquaculture systems specific to V. harveyi were characterized and it was shown that all the 
phages were highly lytic against V. harveyi, displaying different lytic spectra for the large 
number of isolates tested (183 isolates) (Shivu et al, 2007). These phages lysed 15 to 65% of the 
strains. Six of the seven phages have a broad lytic spectrum and could be potential candidates 
for biocontrol of the V. harveyi in aquatic systems. None of the phages were able to infect other 
Vibrio species. Another interesting result using lytic phages against V. harveyi on shrimp farm 
water, showed significant higher survival rates when phage was applied even when comparing 
to results obtained on treatments with daily addition of antibiotics (5 mg L-1 oxytetracyclin and 
10 mg L-1 kanamycin) (Vinod et al, 2006). The results showed that antibiotic treatment led 
to initial reduction of luminous bacteria after forty-eight hours when bacteria proliferate 
to about 106 PFU mL-1 (survival of 40%), but when using specific phages against V. harveyi  
the luminous bacteria were not detected throughout the seventeen day study period (survival of 
86% in the phage treated tank). The phages used in this study did not carried virulence genes. 
The results suggest that bacteriophages have potential for biocontrol of V. harveyi in hatchery 
systems (Vinod et al, 2006). 
In table 1.3 these and other important reports on phage therapy applied to aquaculture 
systems are summarized. 
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Table 1.3: Experiences of phage therapy applications to aquaculture (Almeida et al, 2009). 
Reference Phage Bacteria Treated fish/shellfish Phage application Effects 
Bogovazova et al., 
1991 
Klebsiella pneumoniae 
bacteriophage Klebsiella BALB/c mice 
Intraperitoneal, intravenous or 
intranasal administration 
Rescue of generalized 
Klebsiella infection 
Barrow et al., 1998 Bacteriophage R isolated from domestic sewage 
E. coli H247 
(O18:K1:H7) 
(bacteremic) 
Chickens and 
calves 
Intramuscular (102-106 PFU) 
and intracranial (108 PFU) 
inoculation of chickens; oral 
and intramuscular inoculation 
of calves with 3x1010 PFU) 
Protection against 
morbidity and 
mortality 
Cao et al., 2000 Helicobacter pylori M13 
recombinant phage Helicobacter pylori BALB/c mice 
Oral administration of 107 
PFU 
Reduction of stomach 
colonization by 
Helicobacter pylori 
Flaherty et al., 
2000 
Xanthomonas campestris pv. 
vesicatoria specific H-mutant 
bacteriophages 
Xanthomonas 
campestris pv. 
vesicatoria 
“Sunbeam” 
tomato 
Lycopersicon 
esculentum 
Foliar applications of 108 
PFU/mL phage suspensions 
Reduction of bacterial 
spots and increase in 
fruit weight. 
Leverentez et al., 
2001 Salmonella – specific phages 
Salmonella 
enteritidis 
Fresh-cut fruit 
(melons and 
apples) 
Direct application of 5 x 107 
PFU/mL phage suspension on 
fruit slices 
Reduction of 
Salmonella 
concentration by 2.5-
3.5 logs on melon but 
not on apple. 
Biswas et al., 2002 
Enterococcus phages ENB6 
and C33 isolated from raw 
sewage 
Vancomycin-
resistant 
Enterococcus 
faecium (agent of 
VRE bacteremia) 
BALB/c mice Intraperitoneal injection of 3 x 108 PFU 
Complete rescue of 
bacteraemia in 48 
hours 
Nakai & Park 2002 
Siphoviridae isolated from 
diseased fish and sea water in 
fish culture cages. 
Lactococcus 
garvieae, formerly 
Enterococcus 
seriolicida 
Yellowtail 
Seliora 
quinqueradiata 
and Ayu 
Plecoglossus 
altivelis 
Oral administration of phage-
impregnated feed or 
intraperitoneal injection 
Protective/curative 
effect (increase in the 
survival rate). 
Goode et al., 2003 
Salmonella enteritidis phage 
types P125589, phage 29C and 
transducing lambdoid phage 
P22, HTint, isolated on S. 
enterica serovar Enteritidis 
from sewage; Campylobacter 
jejuni phage 12673 
Salmonella enterica 
serovar Enteritidis 
and Campylobacter 
jejuni 
Chicken skin Surface spreading with 10
3
 
PFU/cm2 
Reduction by 2 log 
units in bacterial 
abundance over 48 h. 
Jado et al., 2003 
Phage-coded lysins 
(enzybiotic): Pal amidase 
and/or Cpl-1 lysozyme 
Antibiotic-resistant 
Streptococcus 
pneumoniae 541, 
serotype 6B 
BALB/c mice 
Intraperitoneal injection of 1 
mg/mL (110 000 U/mg) 
enzyme solutions. 
Rescue of bacteraemia 
and prevention of 
death in 72 hours. 
Hagens et al., 2004 
Genetically engineered non-
replicating, non-lytic 
filamentous phage Pf3R 
obtained from phage Pt1 
isolated from river water using 
PAO1 as the host. 
Pseudomonas 
aeruginosa BALB/c mice 
Intraperitoneal inoculation 
with 106-108 PFU 
Higher survival rate 
and reduced 
inflammatory 
response after 12-24 
hours. 
Fiorentin et al., 
2005 
Salmonella enteritidis lytic 
phages CNPSA 1, CNPSA 3, 
CNPSA 4 
Salmonella 
enteritidis 
Chicken cuts 
(thighs and 
drumsticks) 
Immersion in 109 CFU/mL 
bacteriphage suspensions 
Reduction of 
Salmonella enteritidis 
counts in treated 
chicken cuts. 
Huff et al., 2005 Escherichia coli phages SPR02 
and DAF6 
Escherichia coli iso 
lated from poultry 
Broiler chickens 
 
Injection in the air sac with 
104 or 108 PFU/mL phage 
suspensions and bird spraying 
with phage suspensions. 
Decreased bird 
mortality. 
Toro et al, 2005 Salmonella – specific bacteriophages 
Salmonella 
typhimurium Chicken Oral administration. 
Reduction in 
Salmonella counts in 
cecum and ileum 
treated chickens. 
Wills et al, 2005 Bacteriophage LS2a 
Staphylococcus 
aureus strain 2698 
(abscess forming) 
New Zealand 
White rabbits 
Subcutaneous injection with 2 
x 109 PFU 
Prevention of abscess 
formation 
Verner-Jeffreys et 
al, 2007 
Aeromonas salmonicida phages 
O, R and B 
Aeromonas 
salmonicida subsp. 
salmonicida 
Atlantic salmon 
Salmo salar 
Injection (1.9 x 108 PFU/fish), 
oral administration (1.88 × 105 
PFU/g)  and bath (1.04 × 105 
PFU/mL) 
Lower rate mortality 
but similar absolute 
mortality. No 
protection was offered 
by any of the 
bacteriophage 
treatments. 
Watanabe et al , 
2007 
 
Phage strain KPP10 isolated 
from a highly polluted river 
using P. aeruginosa strain 
PA20 as the host. 
Pseudomonas 
aeruginosa strain D4 
(agent of gut-derived 
sepsis) 
ICR mice Intraperitoneal inoculation 
with 1010 PFU 
Higher survival rate and 
reduced inflammatory 
response after 24 hours. 
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1.3.4. Disadvantages of phage treatment 
Phage therapy is not seen as a consensual and fully established alternative to antibiotics. 
Therapeutic phages have at least some theoretical advantages over antibiotics, and phages have 
been reported to be more effective in treating bacteria infections (Inal, 2003). However, 
identified problems of phage therapy must not be discarded. Some of the more discussed ones 
are the development of antibodies after repeated treatment with phages or, for example, against 
phages used to treat enteric pathogens. 
The problem of antibodies, which could presumably be overcome by theuse of cocktails of 
phages, is not deemed as important as clearance from the bloodstream by the spleen, which is 
much more rapid. Other problems might include the rapid uptake and inactivation of phages by 
the spleen and the contamination of therapeutic phage preparations with endotoxin from 
bacterial debris (Inal, 2003).  
These concerns on phage therapy treatments are being somehow addressed, with 
encouraging results. For example, when purifying phages prepared from bacteria using cesium 
chloride centrifugation, the contamination levels with endotoxin and exotoxin released during 
lytic growth (Merril et al, 1996) were highly diminish (by over 100-fold). Although elimination 
of phages by the reticuloendothelial system can also be avoided by selecting for phage variants 
(at least in mice) able to circulate for a long time after intraperitoneal administration, by a 
natural selection process (the so-called “serial passage technique”) (Merril et al,1996 ) this 
would not be practical and could be overcome by further administration of phages.  
Furthermore, despite the effectiveness of phages in destroying bacteria in vitro, little is 
known about how they behave in vivo, in particular in the human body. 
A consensus objection to the use of phage is its excessive narrow host range in comparison 
with, for example, antibiotics. Such fact is probably due to the presence or absence of the 
attachment antigen but also by potentially greater restriction problems resulting from variations 
in DNA restriction patterns between different isolates of the same organism (Barrow et al, 
1997).  Another approach is to search for phages that attach to the surface virulence 
determinants. These are generally shared by many or all relevant strains and phage-resistant 
bacteria may be attenuated, as indicated previously 
The possibility of using a combination of phages against the major strains of bacteria was 
already tested by Smith (Smith et al, 1983) that developed a phage pool for enterotoxigenic E. 
coli strains. One advantage of using more than one phage for each strain is that, should mutants 
arise that are resistant to a particular phage and are still virulent, a second phage to which the 
strain is susceptible is available. This approach has been used successfully in the E. coli 
diarrhoea work (Smith et al, 1983).  
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Other undesired effect arise when phages do not lyse bacteria but remain as genetic material 
in the cells in a state of lysogeny. Such phages can code for undesirable features of bacteria, 
such as toxin production (Barrow et al, 1997) but they can be avoided. In some infections, the 
invading bacteria are thought to become primarily intracellular within the host. It is quite likely 
that infections with such pathogens, including Salmonella, Brucella, Yersinia and the 
mycobacteria, would not be amenable to this sort of approach. 
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Chapter 2 
Evaluating seasonal dynamics of bacterial communities in marine fish 
aquaculture: a preliminary study before applying phage therapy 
 
Abstract 
The increasing problems with antibiotic resistance in common pathogenic bacteria and the 
concern about the spreading of antibiotics in the environment due to medical treatments in 
humans, animal farms and fish-farming plants, bring the need to find new methods to control 
fish pathogens. Phage therapy represents a potentially viable alternative to antibiotics and other 
antimicrobials. The use of phage therapy in aquaculture requires, however, a detailed 
understanding of bacterial communities, namely of fish pathogenic bacteria, and the awareness 
of various novel kinetics phenomena not known in conventional drug treatments. The 
knowledge of the structure of bacterial communities in aquaculture systems is relevant and must 
be considered in order to test the suitability of phage therapy to control pathogenic bacteria of 
fish. Therefore, in this study the seasonal dynamics of the overall bacterial communities, 
microbiological water quality and disease-causing bacteria were followed in a marine 
aquaculture system of Ria de Aveiro (Portugal). Analysis of the water samples by means of 
denaturing gradient gel electrophoresis (DGGE) of 16S rRNA gene fragments suggested that 
the bacterial community structure varied seasonally, showing a higher complexity during the 
warm season. The main fish pathogenic bacteria, assessed by DGGE targeting the Vibrio genus, 
showed less remarkable seasonal variation, with new dominating populations appearing mainly 
in the spring. Bacterial indicators, faecal coliforms and enterococci were enumerated by the 
filter-membrane method, using selective culture media. A clear seasonal variation was observed 
for bacterial indicators with the highest values in October. The relative abundance of specific 
groups of bacteria was accessed by fluorescence in situ hybridization (FISH), using 16S rRNA-
targeted probes. The FISH results showed that the specific groups of indigenous and non-
indigenous bacteria varied during the study period and that the non-indigenous 
Enterobactereaceae family was the most abundant group followed by Vibrio and Aeromonas. 
The Pseudomonas genus was the less abundant group. As the density and structure of total and 
pathogenic bacterial communities varied seasonally, it is necessary to take in consideration this 
variation when specific phages are selected for phage therapy. The seasonal variation detected 
in this study of the main fish pathogenic bacteria in terms of density and diversity implicates a 
careful monitoring of water along the year in order to select the suitable phages to inactive 
bacteria. 
 
 
 
Keywords: phage therapy, aquaculture, viruses, bacterial community, faecal pollution, seasonal 
variation 
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Introduction 
The increasing importance of aquaculture to compensate the progressive worldwide 
reduction in amount and quality of natural fish populations has contributed to aquaculture 
becoming one of the fastest growing productive sectors, providing nearly one-third of the 
world’s seafood supplies. However, the growth and even survival of the aquaculture industry is 
threatened by uncontrolled bacterial diseases that cause extensive losses (Flegel, 2006; Saksida 
et al, 2006). 
The main biological agents that cause food-borne disease are bacteria, viruses, parasites, 
oomycetes and to a lesser extent moulds (Almeida et al, 2009). Parasite-related food safety 
concerns in aquaculture are limited to a few helminth species, and are largely focused on 
communities where consumption of raw or inadequately cooked fish is a cultural habit (WHO, 
1995). Human viral diseases caused by the consumption of fish appear to present a low risk, 
because viruses that are pathogenic to fish are not pathogenic to man. 
Bacterial diseases are a major problem in the expanding aquaculture industry (Alderman et 
al, 1996; Shao et al, 2001; Wahli et al, 2002). The level of contamination of aquaculture 
products will depend on the environment and the bacteriological quality of the water where the 
fish is cultured. There are two broad groups of bacteria of public health significance that 
contaminate products of aquaculture: those naturally present in the environment – indigenous 
microflora (e.g. Aeromonas hydrophila, Clostridium botulinum, Vibrio parahemolyticus, Vibrio 
cholerae, Vibrio vulnificus and Listeria monocytogenes) and those introduced through 
environmental contamination by domestic animals excreta and/or human wastes – non 
indigenous microflora (e.g. Enterobactereaceae such as Salmonella, Shigella, Escherichia coli) 
(Muroga et al, 1987; Huss, 1994; Fukuda et al, 1996; Iida et al, 1997, Nakai et al, 1999; Nakai 
and Park, 2002). This faecal material can be originated from point source discharges such as 
raw sewage, storm water, effluent from wastewater treatment plants and industrial sources 
(Seurinck et al., 2005). In addition, non-point source discharges such as agriculture, forestry, 
wildlife and urban run-off can also impair water quality (Seurinck et al., 2005). 
Vibriosis and photobacteriosis (formerly pasteurellosis) are primarily diseases of marine 
and estuarine fish, both in natural and commercial production systems throughout the world, 
occurring only occasionally in freshwater fish. Both diseases can cause significant mortality in 
fish, reaching values of up to 100% in infected facilities, being currently responsible for the 
most outbreaks of fish farming plants. Vibriosis and photobacteriosis are caused by bacteria 
from the family Vibrionaceae. Vibriosis is caused by species from the genera Photobacterium 
(namely Photobacterium damselae subsp. damselae, formerly Vibrio damselae) and Vibrio 
(namely V. anguillarum, V. vulnificus, V. alfinolyticus, V. parahaemolyticus and V. 
salmonicida). Photobacteriosis is caused by P. damselae subsp. piscicida (formerly Pasteurella 
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piscicida) that is a highly pathogenic bacterium that does not seem to have host specificity, 
infecting an ample range of fish species (Toranzo et al, 1991; Noya et al, 1995). Other bacteria 
as Aeromonas salmonicida, Rickettsia-like bacteria, Cytophaga marina, Flavobacterium 
psychrophilum and Pseudomonas plecoglossicida are also important groups of fish pathogens, 
affecting a variety of fish species from diverse geographical aquatic environments (Almeida et 
al, 2009). 
Due to the fast worldwide emergence of antibiotic-resistant bacterial pathogens in human, 
medicine, agriculture and aquaculture, regulators are severely limiting antibiotic usage. Phage 
therapy represents a potentially viable alternative to antibiotics and other antimicrobials. When 
compared to other methods based on the direct addition of antibiotic/disinfectant into the 
aquaculture systems, phage therapy present lower risk for fish (Nakai and Park, 2002, Inal et al, 
2003; Clark et al, 2006), inactivating pathogenic bacteria and avoiding fish contamination. The 
safety of the phage therapy approach is additionally increased by the fact that phages do not 
induce the selection of resistant bacterial strains (Inal et al, 2003; Clark et al, 2006; Almeida et 
al, 2009). The possibility to replace at least some of the currently used chemical agents working 
as antimicrobials (e.g., antibiotics bronopol, hydrogen peroxide, formalin), which are potentially 
dangerous for the fish and consumers and invariably cause some degree of environmental 
pollution, adds further value to the phage therapy approach by minimizing the risk of undesired 
side effects and allowing a less risky repetition of the treatment. However, the success of phage 
therapy depends on the level of faecal contamination and on the knowledge of the main 
pathogenic bacteria, having into account their seasonal variation. The main purpose of this work 
was to follow the seasonal dynamics of viral and bacterial communities of aquaculture systems, 
identifying the main pathogenic bacteria groups and evaluating the level of faecal 
contamination. The total number of viruses was also determined in order to evaluate the 
availability of viruses that will be isolated and used in phage therapy 
 
 
Material and Methods 
STUDY AREA 
This study was conducted in the aquaculture system Corte das Freiras located in Ria de 
Aveiro (Figure 2.1). Ria de Aveiro is an estuarine system situated on the north-western coast of 
Portugal. Fish semi-intensive culture for human consumption is an important economic activity 
in Ria de Aveiro.  
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Figure 2.1: Ria de Aveiro with the aquaculture systems Corte das Freiras (A)  
 
SAMPLING 
Water samples were collected two hours before low tide, in mild weather conditions, from 
a culture tank of Sparus aurata (gilthead bream). Samples from surface water were taken 
directly into sterile glass bottles and kept cold and in the shade during transport to the laboratory 
where they were processed within the next 1-2 hours. 
In a first phase it was quantified the main pathogenic bacteria of fish in water samples 
collected on five dates: April 2007, October 2007, December 2007 and February 2008. In a 
second phase, the seasonal dynamics of the bacterial community structure and the total viral 
number were evaluated on, November 2008, January 2009, March 2009, May 2009 and July 
2009. The bacterial indicators (faecal coliforms and enterococci) were analyzed during the all 
study period, on nine different dates: October 2007, December 2007, February 2008, June 2008, 
November 2008, March 2009, May 2009 and July 2009.  
 
WATER PROPERTIES  
Temperature and salinity were measured in the field using a WTW LF 196 Conductivity 
Meter. Dissolved oxygen was also determined in the field with a WTW OXI 96 oxygen meter 
equipped with a WTW BR 190 stirrer. pH was measured in the laboratory, at 25ºC, with a pH 
probe (Orion, Model 290 A). 
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EVALUATION OF THE SEASONAL DYNAMICS OF BACTERIAL COMMUNITY 
STRUCTURE AND OF VIBRIO GENUS. 
Triplicate sub-samples of 300 mL were filtered by 0.22 µm-pore-size filters (Poretics 
Products Livermore, USA). Collected cells were resuspended in 2 mL of TE buffer [10 mM Tris 
HCl, 1 mM ethylenediamine tetraacetic acid (EDTA), pH 8.0] and centrifuged. After 
resuspension in 200 mL TE, 1 mg mL-1 lysozyme solution was added to induce cell lysis and 
incubated at 37ºC for 1 hour, according to the procedure described by Henriques et al (2004) 
.DNA extraction was performed using the genomic DNA purification kit (MBI Fermentas, 
Vilnius, Lithuania). DNA was resuspended in TE buffer and stored at –20ºC until analysis. The 
yield and quality of DNA were checked after electrophoresis on 0.8 % (w/v) agarose gel. 
PCR amplification of an approximately 400 bp 16S rDNA fragment (V6-V8) was 
performed using the primer set F968GC and R1401 (Nubel et al., 1996) .The reaction was 
carried in a Multigene Gradient Thermal Cycler from MIDSCI. The 25 µl reaction mixture 
contained approximately 50 to 100 ng of extracted DNA, 1x PCR buffer (PCR buffer without 
Mg Cl2: PCR buffer with K Cl2, 1:1), 275 Mm MgCl2, 0.2 mM of each nucleotide, 0.1 µM of 
each primer, 1U of Taq Polymerase (all reagents purchased from MBI Fermentas, Vilnius, 
Lithuania). Acetamide (50%, 0.5 µM) was also added to the reaction mixture. The protocol 
included a 4 min initial denaturation at 94ºC, 34 cycles of 95ºC for 1 min, 53ºC for 1 min and 
72ºC for 1 min 30 s, and a final extension for 7 min at 72ºC.  
The diversity of the Vibrio genus was analyzed after amplification of bacterial DNA using 
the primers Vib-F (727) 5’-AGG CGG CCC CCT GGA CAG A-3’ and Vib-R (1423) 5’-ARA 
CTA CCY RCT TCT TTT GCA GC-3’. Each PCR reaction mixture contained: 1x PCR buffer, 
0.2 mM d-NTP’s, 25 mM MgCl2, 0.5% DMSO; 0.2 µM of each primer, 2.5 units Taq, 50 ng of 
the DNA template and 13.25 µL of distilled deionized water to a total reaction volume of 25 µL. 
Thermal cycling was as follows: 1 cycle of 7 min at 94 ºC; 30 cycles of 1 min at 94 ºC, 1 min at 
56 ºC and 1 min at 72 ºC and a final extension of 72 ºC for 10 min. PCR products were checked 
using standard agarose gel electrophoresis and ethidium bromide staining (Sambrook et al., 
1989). 
DGGE was performed with the CBS System (CBS Scientific Company, Del Mar, CA, USA). 
PCR products were loaded onto 6-9% polyacrylamide gel in 1xTAE buffer (20 mmol/L Tris, 10 
nmol/L acetate, 0.5 mmol L-1 EDTA pH 7.4). The 6-9 % polyacrylamide gel 
(bisacrylamide:acrylamide = 37.5:1) was made with a denaturing gradient ranging from 32 to 
60%. Electrophoresis was performed at 60ºC for 16 h at 150 V. Following electrophoresis, the 
gels were incubated for silver staining. The solutions used were 0.1% (v/v) ethanol plus 0.005% 
acetic acid for fixation, 0.3 g silver nitrate for staining, freshly prepared developing solution 
containing 0.003% (v/v) formaldehyde, 0.33% NaOH (9%), and finally, 0.75% sodium 
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carbonate solution to stop the development. GelCompar 4.0 program (Applied Maths) was used 
to analyze bacterial community profiles of the images of DGGE gels as described by Smalla et 
al. (2001). 
QUANTIFICATION OF BACTERIAL INDICATORS OF FAECAL CONTAMINATION 
Samples were analyzed for bacterial indicators, faecal coliforms (FC) and faecal enterococci 
(FE). Faecal coliforms and enterococci were enumerated by filter-membrane method using 
selective culture media, m-FC medium (Difco Laboratories) and m- KF (Difco Laboratories), 
respectively. Faecal coliforms were incubated at 44.5 ºC for 24 hours and enterococci incubated 
at 37ºC for 48 hours. The results were expressed as colonies forming units for one hundred 
milliliters (CFU 100 mL-1).  
 
QUANTIFICATION OF THE MAIN PATHOGENIC BACTERIA OF FISH  
Samples were filtered through 0.22 µm polycarbonate filters (GE Osmonics), fixed with 4 
% paraformaldehyde for 30 min and rinsed with PBS 1X and MilliQ water. The filters were 
stored at room temperature until hybridization. The specific groups of bacteria were accessed by 
Fluorescent in situ hybridization (FISH) using 16S rRNA target probes (Amann et al, 1990). 
The probe Eub338-II-III was used to quantify bacteria belonging to the Domain Bacteria. The 
bacteria belonging to the non-indigenous Enterobacteriacea family and to the Vibrio, 
Aeromonas and Pseudomonas genera were detected with the specific probes ENT183, VIB572a, 
AERO1244 and Pae997, respectively. 
For each probe, three filter sections were placed on a Parafilm-covered glass slide and 
overlaid with 30 µL hybridization solution with 2.5 ng µL-1 of probe. The hybridization solution 
contained 0.9 M NaCl, 20 mM Tris-HCl (pH 7.4), 0.01% SDS, and the optimum concentration 
of formamide for each probe [32]. Filters were incubated in sealed chambers at 46 °C for 90 
min. After hybridization, filters were washed for 20 min at 48°C in wash solution (20 mM Tris-
HCl pH 7.4, 5 mM ethylenediaminetetraacetic acid, 0.01% SDS, and the appropriate 
concentration of NaCl) (Pernthaler et al., 2001) . Rinsed and dried filter pieces were 
counterstained with 2 µg mL-1 4’, 6-diamidino-2-phenylindole (DAPI) and mounted with 
Vectashield and Citifluor (1:4). Besides the relative abundance, DAPI staining also provided a 
measure of total microorganisms. Samples were examined with a Leitz Laborlux K microscope 
equipped with the appropriate filter sets for DAPI and CY3 fluorescence. At least 15 fields were 
counted for each of the three replicates.  
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QUANTIFICATION OF TOTAL VIRAL NUMBER 
Total viral number was determined by epifluorescence microscopy after staining with 
SYBR gold (Noble and Fuhrman, 1998). Water samples were previously filtered by 0.2 µm 
pore-size polycarbonate membrane filters (Poretics Products Livermore, USA) with vacuum 
pressure 150 mm Hg. One milliliter of 0.2µm filtered water was filtered through a 0.02 µm pore 
size AI2O3 Anodisc membrane filter at approximately 20 kPa vacuum. The Anodisc membrane 
was filtered to dryness, removed with forceps with the vacuum still on, and laid the sample side 
up on the drop of the Sybr gold at 2x solution for 15 min in the dark. The Anodisc filter was 
mounted on a glass slide with a drop of 50% glycerol, 50% phosphate buffered saline (PBS, 
0.05 M Na2HPO4, 0.85% NaCl, pH 7.5) with 0.1 % p-phenylenediamine. For each filter, 10 to 
20 fields were selected randomly and a total of at least 200 viruses were counted on an 
epifluorescence microscope (Leitz Laborlux K microscope) equipped with the appropriate filter 
for SYBR gold (Noble and Fuhrman, 1998). 
 
STATISTICS 
Total viral and bacterial numbers were tested for normality (Kolmogorov–Smirnov test) 
before the comparison of means. Parametric analysis of variance (ANOVA) was performed, 
providing that data was normally distributed and that the variance of group means was 
homogeneous (Levene test).  
 
RESULTS 
WATER PROPERTIES  
The range of values of the parameters that describe water properties are summarized in 
Table 2.1. In the aquaculture system, salinity range varied between 35.7 in October 2007 and 
16.7 in December 2007. Temperature oscillated from 10.8°C in November 2007 to 20.8°C in 
June 2008 and the dissolved oxygen ranged between 1.55 mg L-1 in July 2009 and 6.01 mg L-1 
in April 2006. 
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Table 2.1: Physical characterization of the water in the aquaculture system during the study 
period. 
 
 
Sampling dates Salinity Temperature (ºC) 
Dissolved 
Oxygen (mg L-1) 
 
pH 
April 2007 32.1 17.7 6.01 7.38 
October 2007 35.8 16.9 4.64 7.90 
December 2007 16.7 13.4 2.78 8.02 
February 2008 31 16 3.41 809 
June 2008 31.4 20.8 5.65 7.70 
November 2008 29.5 10.8 2.87 8.05 
January 2009 19.7 12.8 2.67 7.98 
March 2009 31 13.8 2.43 8.09 
May 2009 31.4 17.5 2.70 8.19 
July 2009 32.8 20.1 1.55 8.02 
 
EVALUATION OF THE SEASONAL DYNAMICS OF BACTERIAL COMMUNITY 
STRUCTURE AND OF VIBRIO GENUS. 
Bacterial community structure was examined by comparing DGGE profiles of 16S rDNA 
fragments during the different sampling moments (Figure 2.2). Reproducibility of PCR 
amplification and DGGE was confirmed by similar results obtained for the three sub-samples 
analyzed at each date (Figure 2.2). 
DGGE profiles revealed a complex and specific pattern of bands (Figure 2.2) in 
aquaculture water samples as well as seasonal differences in the structure of bacterial 
communities, with a higher diversity during the warm season. Bray-Curtis similarity index for 
bacterial community ranged between ~25% and ~97%, varying widely between sampling 
moments. Cluster analysis of the band patterns obtained from DGGE analysis (Figure 2.3) 
revealed the occurrence of weak similarities (as low as 25%) between the bacterial community 
structures in water samples collected in the different months. The bacterial community in the 
water sample collected in March showed the lowest value of similarity (~25%) with those 
detected in the remaining sampling periods. For the other months, the bacterial communities 
present in the water samples collected in November and January showed the highest similarity 
index (> 85%). 
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Figure 2.2: Seasonal DGGE profile of 16S rDNA of 
bacterial communities of the aquaculture system.  
Figure 2.3: Dendrogram generated from the 
pattern of bands obtained by DGGE (figure 2.2) 
of aquaculture water. 
 
 
 
Bray-Curtis similarity index for Vibrio ranged between ~80% and ~96%, varying between 
sampling moments (figure 2.5). Cluster analysis of the band patterns obtained from DGGE 
analysis (Figure 2.4) revealed that the diversity of Vibrio in water samples collected in 
November showed the lowest similarity value (<80%) with the remaining sampling moments. 
The samples displaying the highest similarity values (~92%) were those collected in the months 
of January and March.  
 
 
 
 
 
Figure 2.4: Seasonal DGGE profile of Vibrio 16S 
rDNA.in an  aquaculture system  
Figure 2.5: Dendrogram generated from the 
pattern of bands obtained by DGGE (figure 9) of 
aquaculture water. 
 
 
QUANTIFICATION OF BACTERIAL INDICATORS OF FAECAL CONTAMINATION 
The results of the number of faecal coliforms and enterococci presented in the aquaculture 
system are represented in Figure 2.6. The concentrations of faecal coliforms were, in general, 
slightly higher than those of for enteroccoci. The differences observed for faecal coliforms and 
enterococci densities during the sampling period were significant (ANOVA< 0.05). 
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Figure 2.6: Seasonal variation of faecal coliforms and enterococci in the aquaculture system. 
In general, the values of the faecal indicators decreased during the sampling period. The 
highest values of enterococci were obtained in October 2007 (45.33 UFC. 100mL-1) and the 
lowest in May 2009 (5.33 UFC. 100mL-1). Over the cold months (October, November and 
December) a clear decrease in the abundance of faecal coliforms was noticed, reaching its lower 
values on May and June. The highest values of faecal coliforms were obtained in July 2009 
(36.33 UFC. 100mL-1) and the lowest in June 2008 (4.00 UFC. 100mL-1). 
 
QUANTIFICATION OF MAIN PATHOGENIC BACTERIA OF FISH  
The relative abundance of bacteria belonging to Bacteria domain as well as 
Enterobacteriacea family and Vibrio, Aeromonas and Pseudomonas genera detected by FISH is 
shown in Figures 2.7 and 2.8. The relative abundance of the Bacteria domain varied between 
76.63 ± 1.05% in December 2007 and 95.40 ± 0. 97% in February 2008, relatively to the DAPI 
counts. The differences observed for total bacterial number were not significantly different 
during the sampling period (ANOVA, p > 0.05). 
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Figure 2.7: Relative abundance of the Bacteria domain detected by FISH in the aquaculture system. 
 
The most abundant specific group of bacteria in October 2007 and February 2008 is the 
Enterobacteriacea family, whereas in December 2007 and April 2007 is the Aeromonas genera. 
The least abundant group over the different sampling dates was the Pseudomonas genera. On 
April 2007, the relative abundance of the four groups of fish pathogenic bacteria was similar 
(ANOVA, p > 0.05) but in the other months, a wide variation was observed in the relative 
abundance of the four studied groups (ANOVA, p < 0.05). 
 
 
Figure 2.8: Relative abundance of Enterobacteriacea family, Vibrio, Aeromonas and Pseudomonas 
genera detected by FISH in the aquaculture system. 
The relative abundance of Enterobacteriaceae family was higher in October 2007 (5.77± 0. 
53%), decreasing over the winter and spring seasons and reaching its lower values on April 
2006 (2.29±0.7%). Aeromonas presented the highest relative abundance values in December 
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2007 (5. 55 ± 0.23%) and the lowest on February 2008 (1.05±0.22%). An increase on the 
relative abundance of Vibrio was observed between October 2007 (1.94± 0.17%) and February 
2008 (3.86± 0.04%) and the highest values of Pseudomonas were obtained in April 2007 (2.29 
±0.2%) and the lowest in February 2008 (0.96±0.04%). 
QUANTIFICATION OF TOTAL VIRAL NUMBER 
The results of the total viral number in the aquaculture system are represented in Figure 
2.9. Viral abundance varied between 6.10 x 109 particles L-1 in May 2009 and 1.09 x1010 
particles L-1 in March 2009. The total viral number at each moment of sampling was 
significantly different (ANOVA< 0.05). 
 
 
Figure 2.9: Seasonal variation of viruses in the aquaculture system. 
 
Discussion 
The success of phage therapy depends on the knowledge of the density of the main 
pathogenic bacteria, as well as of their seasonal variation. In general, the total bacterial numbers 
were fairly constant over the year, but the relative abundance of specific bacterial groups varied 
significantly during the sampling period. Among potentially pathogenic bacteria, 
Enterobacteriaceae were de most abundant, indicating that non-indigenous pathogenic bacteria 
are an importance source of contamination in this aquaculture system. In fact, the indicators of 
faecal contamination, faecal coliforms and enteroccocci, were present during all the sampling 
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period in the aquaculture system, confirming the importance of these bacterial groups in 
aquaculture. Although there is a rapid die-off of these enteric bacteria in managed farm fish, 
significant numbers of those bacteria remain on the skin and in the guts of fish and can cause a 
health risk to consumers (Almeida et al, 2009). Aeromonas and Vibrio genera that include A. 
salmonicida, causative agent of furunculosis (Bernoth, 1997), that is capable of infecting a wide 
range of host species, and members of the family Vibrionaceae that are currently responsible for 
the most outbreaks of fish farming plants, were also present at high concentrations in the 
aquaculture system (Toranzo et al, 1991; Noya et al, 1995). Consequently, phages of 
Enterobacteriaceae, Aeromonas and Vibrio groups must be considered in phage therapy. 
The results of this study show that the bacterial community structure in general and, more 
specifically, that the diversity of the bacterial group most implicated in fish farming plants 
outbreaks (Vibrio genus) varied seasonally, indicating that it is necessary to take in 
consideration this variation when specific phages are selected to inactive fish pathogenic 
bacteria. Although the seasonal variation of the Vibrio genus was milder than that of the total 
bacterial community, the primers used to analyze the diversity of fish pathogens belonging to 
this genus (e.g. V. anguillarum, V. vulnificus, V. alfinolyticus, V. parahaemolyticus and V. 
salmonicida) also detect species from the Photobacterium genus (P. damselae subsp. damselae, 
formerly Vibrio damselae; and P. damselae subsp. Piscicida, formerly Pasteurella piscicida) 
that cause vibriosis and photobacteriosis (formerly pasteurellosis) that are primarily diseases of 
marine and estuarine fish, both in natural and commercial production systems throughout the 
world (Toranzo et al, 1991; Noya et al, 1995) . 
The density of viral community in the water column of the aquaculture system (ranging 
from 6.10 x 109 - 1.09 x 1010 particles L-1) could suggest a strong overall effect on the planktonic 
system and, eventually, a modulation of bacterial community. These values are in accordance 
with the ones obtained on other studies developed in the Ria de Aveiro (Almeida et al, 2007) 
where the total number of viruses varied between 0.1 to 3.7 x1010 cells L-1. Despite the fact that 
the abundance of bacteriophages was not determined, studies made on the same estuarine 
system suggest that the majority of the existing viruses are bacteriophages (Almeida et al, 
2001). The number of viruses in the estuarine system is high, exceeding bacterial abundance by 
more than one order of magnitude (average 17.6) (Almeida et al, 2001). Moreover, the majority 
of the viruses are in the bacteriophage size-range and the patterns of viral density followed those 
of bacterial abundance, explaining 40 % of virioplankton variation. Experimental data of 
microcosm assays showed also that, in the Ria de Aveiro, bacterial lysis by viral infection is 
effective in reducing the density of bacteria below the values determined by predation, namely 
in brackish water (59% against 36% in the marine zone) (Almeida et al, 2001). Although the 
concentrations of bacteriophages in aquatic environments determined by PFU enumeration on 
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various bacteria hosts usually are in the order of 1000 to 10000 PFU L-1 Farrah, 1987; Moebus, 
1987), in the Kiel Bight is up to 3.65 x 107 PFU L-1 ( Ahrens,1971). Torrella and Morita (1979) 
used electron microscopy and estimated the total number of phage particles to be >107 L-1 in the 
seawater from Yaquina Bay, Oregon. Bergh et al. (1989) found abundances of 1 x 105 to 2.5 x 
1011 phages PFU L -1 in various aquatic samples. These studies suggest that the concentration of 
phages in marine waters may be much higher than indicated by the concentrations obtained by 
culturing methods. Bergh et al. (1989) concluded that the high concentrations of bacteriophages 
in aquatic environments indicate that viruses may play important roles as agents of bacterial 
mortality and also control bacterial diversity in nature.  
The seasonal variation of the overall bacterial community and of the disease-causing 
bacteria as well as of the indicators of microbiological water quality implicates a careful 
monitoring of water along the year in order to select the suitable phages to inactive fish 
pathogenic bacteria. The high content of virus in the aquaculture system suggests that it will be 
easy to isolate specific phages of fish pathogenic bacteria. 
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Chapter 3 
Bacteriophages with potential for inactivation of fish bacterial pathogens - effects on 
bacterial community structure 
 
Abstract 
 
Bacterial diseases can cause heavy losses in the fish production industries. The increasing problem of 
antibiotic resistance in common pathogenic bacteria and the concern about spreading of antibiotics in the 
environment, bring the need to find new methods to control fish pathogenic bacteria. Phage therapy 
represents a potentially viable alternative to antibiotics and other antimicrobials to inactivate pathogenic 
bacteria in aquaculture systems. 
The use of phage therapy, however, requires an awareness of various novel kinetics phenomena not 
applied to conventional drug treatments. Therefore, in order to evaluate the use of phage therapy in 
aquaculture, preliminary studies are needed. The objective of this work was to determine the survival of 
Aeromonas salmonicidae and Vibrio parahemolyticus phages in marine water and to study the impact of 
these two viruses on the structure of the bacterial community of the aquaculture system. In order to 
evaluate the suitability of these viruses for phage therapy, their host specificity was also evaluated and 
compared with the specificity of other phages of six pathogenic bacteria isolated in the aquaculture 
system. The survival of the phages was determined after phage addition to filtered water samples through 
the quantification of phages by the soft agar overlay technique. The ecological impact of phage addition 
on the structure of bacterial community was evaluated using 16S rDNA DGGE. The host specificity of 
the phages was evaluated by spotting 10 µl of the marine phage suspension on confluent layers of the six 
host bacteria. 
The survival period of the phages in marine water varied between 12 and 91 days, being the survival 
of Aeromonas salmonicidae phages clearly higher relatively to the other phage tested. The addition of 
specific phages of pathogenic bacteria had a low ecological impact on the structure of the natural bacterial 
community. The cross infection results showed that, with the exception of Aeromonas salmonicida and 
Escherichia coli phage, the phages showed a large spectrum range of host pathogenic bacteria. 
The results of this study show that the high survival of phages in marine water associated with the low 
impact of phages on total bacterial community structure and the high impact of specific phages on a large 
range of pathogenic bacteria, indicate that the phage isolated in this study can be successfully applied to 
inactivate fish pathogenic bacteria, even those resistant to antibiotics. 
 
 
Keywords: Phage therapy, bacteriophages, fish pathogenic bacteria, aquaculture, bacterial community 
structure 
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Introduction 
Aquaculture comprises all types of culture of aquatic animals and plants in fresh, brackish 
and marine environments (Pillay et al, 2005). Nearly one-third of the world’s seafood supplies 
come from aquaculture industry, representing the fastest growing agricultural sector. Over the 
past ten years, aquaculture production has increased on average by 6 % per year (FAO, 2009). 
The production has increased from 8.7 million tons of fish in 1990 to 31.6 million tons in 2006 
(FAO, 2009; FAO, 1998). Fish farming plants, however, often suffer from heavy financial 
losses (Subasinghe et al, 2001; Flegel, 2006; Saksida et al, 2006) due to the development of 
infections caused by microbial pathogens, including multidrug resistant bacteria that are easily 
transmitted through water and therefore able to infect a great variety of fish species. 
Although vaccination is the ideal method to prevent infectious diseases, commercially 
available vaccines are still very limited in the aquaculture field (Reed and Francis-Floyd, 1996; 
Romalde, 2002; Arijo et al, 2005; Lin et al, 2006). This is partly due to the fact that many 
different kinds of infectious diseases occur locally in a variety of fish and shellfish species 
(Nakai and Park, 2002). On the other hand, chemotherapy is a rapid and effective method to 
treat or prevent bacterial infections, but frequent use of antibiotics has allowed drug-resistant 
strains of bacteria to develop. This problem can be particularly serious since few 
chemotherapeutic drugs are licensed for fisheries use (Muroga, 2001; Nakai and Park, 2002). 
Bacterial diseases are a major problem in the expanding aquaculture industry (Alderman, 
1996; Shao, 2001; Wahli et al, 2002). The level of bacterial contamination of aquaculture 
products by pathogenic bacteria will depend on the environment and the bacteriological quality 
of the water where the fish is cultured. There are two broad groups of bacteria of public health 
significance that contaminate products of aquaculture: those naturally present in the 
environment - the indigenous microflora (e.g. Photobacterium damselae, Vibrio sp, Aeromonas 
hydrophila, Clostridium botulinum) and those introduced through environmental contamination 
by domestic animals excreta and/or human wastes – non-indigenous microflora (e.g. 
Enterobactereaceae such as Salmonella sp., Escherichia coli) (Muroga et al, 1987; Huss, 1994; 
Fukuda et al, 1996; Iida et al, 1997, Nakai et al, 1999; Nakai and Park, 2002). 
To reduce the risk of development and spreading of antibiotic resistant bacteria, other more 
environmentally friendly methods to control fish disease in aquaculture must be developed. In 
line with this idea, the use of bacteriophage therapy in aquaculture seems to be very promising. 
Though bacteriophages have been discovered over 80 years ago (Summers, 1999; Comeau et al, 
2008) their potential application as an alternative to antibiotics has been recognized only 
recently (Angly et al, 2006; Culley et al 2006, Allen et al, 2008). Recent studies testify the use 
of bacteriophages as biocontrol agents in different areas (Toro et al, 2005; Flaherty et al, 2000; 
Withy et al, 2005). Although, phages of fish-pathogenic bacteria have been described 
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(Stevenson and Airdrie, 1984; Merino et al, 1990), there have been few attempts to use phages 
to control bacterial infections in fish (Park et al, 2000; Nakai and Park, 2002; Park and Nakai, 
2003; Verner-Jeffreys et al, 2008). Phage therapy has several potential advantages over 
chemotherapy such as: specific target; limited resistance development, limited impact, unlike 
antibiotics, phages are self-replicating as well as self-limiting, simple regulatory approval, high 
resistance of phages to environmental conditions, technology flexible, fast and cheap (Inal, 
2003; Clark and March, 2006). Despite phage specificity being seen as an advantage of phage 
therapy, Miller et al (2003) opposed this fact. In his study, a broad-host-range vibriophage, 
KVP40 was isolated from sea water, using Vibrio parahaemolyticus 1010 (EB101) as the 
indicator host. The host range of KVP40 extended over at least eight Vibrio sp. and one 
Photobacterium sp. (Miller et al, 2003.). 
The success of phage therapy to control pathogenic bacteria of fish depends on virus density, 
but also on their survival and viability in culture water of fish-farming plants. These enteric 
viruses can remain infective for long periods in the environment and have been reported to 
survive for up to 130 days in seawater and up to 120 days in freshwater and sewage, at 20 to 
30°C (Moebus, 1992). However, virtually no formation is available on marine phage survival 
(Kapuscinski and Mitchell, 1980). 
The success of phage therapy also depends on the effect that phages have on the bacterial 
community, namely when extensive and semi-extensive regimes are used. Although phages 
only infect specific bacterial species or even strains of bacteria, potentially causing less damage 
to the bacterial community structure of aquaculture waters, a careful environmental evaluation 
must be done before the implementation of a phage therapy procedure to inactivate bacteria in 
aquaculture systems. In semi-intensive and extensive aquaculture systems, non-pathogenic 
bacteria have a central role in the functioning and productivity of these ecosystems. Bacteria are 
the most important biological component involved in the turnover (transformation and 
remineralization) of organic matter in aquatic systems (Cho and Azam, 1990; Pomeroy et al, 
1991). In coastal waters, heterotrophic bacteria may utilize as much as 40% of the carbon fixed 
by the primary producers (Cole et al, 1988; Cho and Azam, 1990; Ducklow and Carlson, 1992). 
Heterotrophic bacteria are particularly skilled for organic matter transformation. They hydrolyze 
dissolved and particulate organic matter and can use substrates of difficult degradation and even 
different allochtonous compounds as further sources of organic carbon. They convert dissolved 
organic carbon that would inevitably be lost to higher trophic levels (microbial loop). Through 
remineralization of organic matter, bacteria regenerate nutrients which are then use by primary 
producers (Simon and Azam, 1989). As a large fraction of bacteria is not culturable, thus not 
detected by traditional methods, molecular tools (as denaturating gradient gel electrophoresis - 
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DGGE) must be used to evaluate the effect of phage therapy on the general bacterial community 
structure.  
The main objectives of this work were to isolate bacteriophages resistant to environmental 
conditions with potential to inactivate fish pathogenic bacteria, without majorbeffects on the 
bacterial community structure of aquaculture waters. 
Material and Methods 
STUDY AREA 
This study was conducted in the estuarine system Ria de Aveiro (Figure3.1) located on the 
northwest Atlantic coast of Portugal (40°5´N, 8°8´W), where the semi-intensive culture of fish 
is an important economic activity. Water samples were collected in the aquaculture system 
Corte das Freiras, located near the city of Aveiro, which is subjected to contamination 
introduced by human wastes and where chemotherapy treatments are commonly applied. 
 
Figure 3.1: Ria Aveiro (Portugal). 
 
SAMPLING 
Samples were collected in a culture tank of Spanus aurata (gilthead bream), two hours 
before low tide water. Sampling was conducted with mild weather conditions. Samples from 
underlying waters were taken directly into sterile glass bottles and kept cold and in the shade 
during transport to the laboratory where they were processed within the next 1-2 h. 
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WATER PROPERTIES  
Temperature and salinity were measured in the field using a WTW LF 196 Conductivity 
Meter. Dissolved oxygen expressed as the percentage of saturation, was also determined in the 
field with a WTW OXI 96 oxygen meter equipped with a WTW BR 190 stirrer. pH was 
measured in the laboratory, at 25ºC, with a pH probe (Orion, Model 290 A). 
BACTERIA ISOLATION AND IDENTIFICATION 
Three of the strains used in this study were isolated from water samples of the aquaculture 
system, using Tryptic Soy Agar (TSA; Difco) and Thiosulfate Citrate Bile Salts (TCBS; Difco), 
both supplemented with 1.5% NaCl. The plates were incubated aerobically at 25°C and at 37°C, 
during 3-5 days.The other three strains Photobacterium damselae damselae, Photobacterium 
damselae piscicidae and Escherichia coli used in this work were obtained in previous studies 
(Costa et al, 2008; Romalde, 2002).  
Phenotypic identification was performed according to Bergey’s Manual of Systematic 
Bacteriology (Garrity,1984). The tests used were: Cytochrome oxidase, Catalase and  
Tryptophanase activity, Carbohydrate Fermentation, Citrate, Oxidation/Fermentation of 
Glucose, Mobility, O/129 sensibility, growth at 42°C and at different NaCl concentrations. API 
20E system evaluation was also applied to all isolates. After phenotypic identification, the 
isolates were identified by molecular techniques.  
Strains identification confirmation was done by nucleotide sequence analyses. DNA was 
extracted with Fermentas Genomic DNA Purification kit (K0512), according to the procedure 
described by Henriques et al (2004).  The 16S rDNA sequence was amplified with the universal 
primers 27F (5’- AGA GTT TGA TCC TGG CTC AG-3’) and 1494R (5’-TAC GGT TAC CTT 
GTT ACG AC-3’). A reaction mixture of 25 µl was prepared containing 1 x PCR buffer 
(Fermentas, Vilnius, Lithuania), 0.2 mM deoxynucleoside triphosphates, 3.75 mM MgCl2, 4 % 
(vol/vol) bovine serum albumin (BSA - Sigma), , 0.1 µM primers , 1U Taq polymerase 
(Fermentas, Vilnius, Lithuania), and template DNA (ca. 10 ng). The amplification cycle was 
94°C for 5min followed by 32 cycles of 94°C for 45s, 56°C for 45s, 72°C for 1:30min, with a 
final extension of 72°C for 10min. Amplification was confirmed by electrophoreses (1% 
agarose, 1x TAE buffer; 100V for 35min). The 16S rRNA gene sequences obtained from the 
isolated strains were sequenced using the primer 27F. Sequences were classified according to 
the Naive Bayesian rRNA Classifier (Version 1.0) of the Ribosomal Database Project II 
(http://rdp.cme.msu.edu/) and compared with different sequences available in the GenBank 
database using BLAST-N (http://www.ncbi.nlm.nih.gov/BLAST/). 
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CHARACTERIZATION OF BACTERIAL RESISTENCE TO ANTIBIOTICS 
The resistance of fish bacterial pathogens (Vibrio anguillarium, Vibrio parahemolitycus, 
Aeromonas salmonicida, Photobacterium damselae damselae, Photobacterium damselae 
piscicidae and Escherichia coli) to antibiotics was determinate by the disk method (Oxoid) 
according to the manufacturer instructions. The antibiotics tested were: tetracycline, 
ciprofloxacin, erythromycin, chloramphenicol, amoxacillin + clavulanic acid, penicillin G, 
ampicillin, imipenem and neomycin. The diameter of the innibition zone was measured and 
compared with that indicated in the manufacturer intructions in order to classify the bacteria as 
sensitive or resistant to the antibiotics. 
PHAGES ISOLATION AND SUSPENTION PREPARATION 
Six pathogenic bacteria of fish (Vibrio anguillarium, Vibrio parahemolitycus, Aeromonas 
salmonicida, Photobacterium damselae damselae, Photobacterium damselae piscicidae and 
Escherichia coli) were used as hosts to produce phage suspensions in aquaculture water. 
Five hundred milliliters of water was filtered sequentially by 3 µm and then 0.45 µm -pore-
size polycarbonate membranes (Millipore). Filtered water was added of five hundred milliliters 
of Tryptic Soy Broth (Merck) with double concentration and one milliliter of bacterial culture. 
The mixture was left at ambient temperature (25 °C) for 12–18 hours and filtered through 0.45 
µm pore-size membranes. The filtrate was tested for the presence of phages by inoculating 25 µl 
of it on lawns of bacterial culture prepared on tryptone soy agar (Merck). The plates were left at 
ambient temperature (25 °C) for 12–18 h and inspected for zones of clearing. Areas of clearing 
were cut out and inoculated in fresh specific bacterial culture in Tryptic Soy Broth (Merck) in 
order to obtain isolated phage plaque. The mixture was left at ambient temperature (25 °C) for 
10-12 hours and filtered through 0.45 µm pore-size membranes (Millipore). Phage stocks were 
stored at 4°C with 1% of chloroform. 
To determine the phage suspension titer the soft agar overlay technique was used (Adams, 
1959). Phage suspensions were serially diluted in PBS and 500 µl of each phage dilution as well 
as 100 µl of fresh bacterial culture were added to 4 mL of molten soft agar tubes. The mixture 
was rolled between palms to enhance good mixing and overlaid on tryptone soy agar plates. 
After the plates were incubated at ambient temperature (25 °C) for 10–12 hours, the number of 
plaques was counted and the results expressed as plaque forming units per milliliter (pfu mL-1). 
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DETERMINATION OF PHAGE HOST RANGE 
To determine the phage host specificity, the soft agar overlay technique was used (Adams, 
1959). Three hundred microliters of fresh bacterial culture were added to 4 mL of soft soy agar 
and overlaid on TSA plates. After solidification, 10 µl phage suspensions were inoculated on the 
plates. The plates were incubated at ambient temperature (25°C) over 10–12 hours to observe 
the presence /absence of phages plaques. 
PHAGE SURVIVIAL DETERMINATION 
The survival of Aeromonas salmonicidae and Vibrio parahemolyticus phages was tested in 
marine water. One hundred milliliters of water were filtered through 3 µm pore-size filters and 
then by 0.22 µm pore-size membranes (Poretics Products Livermore, USA). Filtered water was 
added of 50 µl of phage suspension. Phage titer was determined at time zero and at intervals of 
72 h, using the soft agar overlay technique. 
IMPACT OF PHAGES ADDITION ON BACTERIAL COMMUNITY STRUCTURE 
150 mL of aquaculture water were added to each of nine erlenmeyers. Three of the 
erlenmeyers were added of phage suspensions: 100µl of stock with 6.15 x 109 PFU mL-1 
(Aeromonas salmonicidae) or 250µl of stock with 1.7 x 1010 PFU mL-1 (Vibrio 
parahemolyticus). The other three erlenmeyers were added, respectively, of 100 or 250 µl of 
Tryptic Soy Broth (TSB) and 1% of chloroform and were used as controls (since the phages 
were preserved in TSB and chloroform). All the erlenmeyers were incubated at ambient 
temperature during 10 hours. After incubation, the samples were filtered through 0.2 µm pore-
size filters. 
For the extraction of bacterial DNA, 150 mL of samples from the different treatments were 
filtered through 0.22 µm pore-size membranes (Poretics Products Livermore, USA) and 
bacterial cells retained on the membranes were resuspended in 2 mL of TE buffer [10mM Tris 
HCl, 1mM ethylenediamine tetraacetic acid (EDTA), pH 8.0] and centrifuged. After 
resuspension in 200 mL TE, 2 mg mL-1 lysozyme solution was added to induce cell lysis and 
incubated at 37ºC for 1 hour according to the procedure described by Henriques et al (2004). 
DNA was resuspended in TE buffer and stored at –20ºC.  
The DNA extracted was used to amplify 16 rDNA gene fragments, using a nested PCR 
approach. In the first PCR, the universal bacterial primers 27F and 1494R were used to amplify 
ca. 1450 bp of the 16S rDNA gene (Weisburg et al., 1991). A reaction mixture of 25 µl was 
prepared containing 1 x PCR buffer (Fermentas, Vilnius, Lithuania), 0.2 mM deoxynucleoside 
triphosphates, 3.75 mM MgCl2, 4 % (vol/vol)  bovine serum albumin (BSA, Sigma) , 0.1 µM 
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primers synthesized by IBA , 1U Taq polymerase (Fermentas, Vilnius, Lithuania), and template 
DNA (ca. 10 ng). After 5 minutes of denaturation at 94 °C, 30 thermal cycles of 45 s at 94 °C, 
45 s at 56 °C, and 1.5 minutes at 72 °C were carried out. A final extension step at 72°C for 10 
min was performed to finish the reaction. One µl of the product of the first PCR was used as the 
template for a second PCR with bacterial DGGE primers F968-GC and R1401 (ca. 347 bp) 
according to Nubel et al. (1996). The reaction mixtures (25 µl) consisted of 1 µl template, 1 x 
PCR buffer (Fermentas, Vilnius, Lithuania), 0.2 mM deoxynucleoside triphosphates, 2.5 mM 
MgCl2, 4 % (vol/vol) acetamid (Fluka), 0.1 µM primers and 1 U DNA Taq polymerase 
(Fermentas). PCR products were checked using standard agarose gel electrophoresis and 
ethidium bromide staining (Sambrook et al., 1989). 
Samples containing approximately equal amounts of PCR amplicons were analysed by 
DGGE, performed with a CBS System (CBS Scientific Company, Del Mar, CA, USA). 
PCR products were loaded onto 6-9% polyacrylamide gel in 1xTAE buffer (20 mmol/L Tris, 10 
nmol/L acetate, 0.5 mmol L-1 EDTA pH 7.4). The 6-9% polyacrylamide gel 
(bisacrylamide:acrylamide = 37.5:1) was made with a denaturing gradient ranging from 32 to 
60%. Electrophoresis was performed at 60ºC for 16 h at 150 V. Following electrophoresis, the 
gels were silver stained. The solutions used were 0.1% (v/v) ethanol plus 0.005% acetic acid for 
fixation, 0.3 g silver nitrate for staining, freshly prepared developing solution containing 
0.003% (v/v) formaldehyde and 0.33% Na OH (9%), and finally, 0.75% sodium carbonate 
solution to stop the development. GelCompar 4.0 program (Applied Maths) was used to analyze 
bacterial community profiles of the images of DGGE gels as described by Smalla et al. (2001)  
 
Results 
BACTERIA ISOLATION AND IDENTIFICATION 
The three bacterial strains isolated from the aquaculture systems were gram-negative 
and were identified as Vibrio anguillarium, Vibrio parahemolyticus and Aeromonas 
salmonicida, based on phenotypic characteristics of this species (Table 3.1). 
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Table 3.1: Phenotypic identification of the Vibrio anguillarium, Vibrio parahemolyticus and Aeromonas 
salmonicida.  ( + : Positive test, - : Negative test , R:Resistance and S: Sensitive). 
  
Bacteria 
Tests Vibrio 
anguillarum 
Vibrio 
parahaemolyticus 
Aeromonas 
salmonicida 
Gram Stain - - - 
Cytochrome Oxidase + + + 
Catalase Activity + + + 
Indol test + + - 
Methyl Red test - + + 
Citrate + + - 
Mobility test + + - 
Oxidation/Fermentation of 
Glucose - + + 
Growth at 42°C + + - 
Methyl Red test  - + + 
TSB +NaCl 
0% + - + 
3% + + + 
6% - + + 
8% - + + 
10% - - + 
Voges-Proskauer 
test   + - - 
O/129 Sensibility 
10µg S S R 
150µg S S R 
 
The results of the analysis of the gene sequences rRNA 16S are presented in Table 3.2. 
The isolate 2A presented a homology of 99% with Vibrio anguillarium, the isolate 3-2 
presented a homology of 99% with  Vibrio parahemolyticus and the isolate 7-2 presented a 
homology of 99% with Aeromonas genus. 
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Table 3.2: Phylogenetic affiliation and percent similarity with the closest relative of rRNA gene clones of 
the bacterial isolates in aquaculture system. 
 
 
Classificação RDPb 
Classe/Ordem/Family 
 
Identidade 
BLAST‐N % 
Nº de 
Accessiona 
Bacteria 
 
2A 
Gammaproteobacteria 
Vibrionales 
Vibrionaceae 
Listonella 
        Vibrio anguillarium 99 
 
X16895 
3-2 
Gammaproteobacteria 
Vibrionales 
Vibrionaceae 
Vibrio 
Vibrio parahemolyticus 99 
 
EF203212 
7-2 
Gammaproteobacteria 
Aeromonadales 
Aeromonadaceae 
Aeromonas 
Aeromonas salmonicida 99 
 
P000644 
 
a
 Genebank access number of the most similar sequence 
b RDP classification - Ribossomal Database Project 
CHARACTERIZATION OF BACTERIAL RESISTANCE TO ANTIBIOTICS 
The results of the resistance of fish bacterial pathogens (Vibrio anguillarium, Vibrio 
parahemolitycus, Aeromonas salmonicida, Photobacterium damselae damselae, 
Photobacterium damselae piscicidae and Escherichia coli) to antibiotics (tetracycline, 
ciprofloxacin, erythromycin, chloramphenicol, amoxacillin + clavulanic acid, penicillin G, 
ampicillin, imipenem and neomycin) are presented in Table 3.3. 
Fish bacterial pathogens showed the highest resistance to antibiotics imipenem and 
neomycin, followed by ampicillin and erythromycin. All the bacteria were sensitive to 
Ciprofloxacin. Vibrio parahemoliticus showed the highest antibiotic resistance . Vibrio 
anguillarium and Aeromonas salmonicidae were the most sensitive bacteria to the tested 
antibiotics. 
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Table 3.3: Resistance of pathogenic bacteria antibiotics (R: resistant; S: sensitive and RI: intermediate resistance) 
ANTIBIOTICS Vibrio 
anguillarium 
Aeromonas 
salmonicida 
Photobacterium 
damsela 
damselae 
Photobacterium 
damsela 
piscicida 
Vibrio 
parahemolyticus E.coli 
Tetracyclin S S S RI RI S 
Ciprofloxacin S S S S S S 
Erythromycin S S R S R RI 
Chloramphenicol S S R S S S 
Amoxacillin + clavulanic acid S S S S R S 
Penicillin G RI S R S R R 
Ampicillin S RI S RI RI RI 
Imipenem R R R R R R 
Neomycin RI R S RI R S 
PHAGES ISOLATION AND SUSPENTION PREPARATION 
Using the isolated bacteria, phage suspensions of Vibrio anguillarium, Aeromonas 
salmonicidae, Photobacterium damselae subsp damselae, Photobacterium damselae subsp. 
piscicida, Vibrio parahemoliticus and Escherichia.coli were obtained with titers varying from 
6.50x108 to 3.00 x1010 PFU/ml. 
DETERMINATION OF PHAGE HOST SPECIFITY 
The results of phage specificity to different host bacteria are presented in Table 3.4. 
With the exception of Aeromonas salmonicidae, the isolated phages showed a large spectrum 
of infection, infecting all the pathogenic bacteria tested (Table 3.4.). Although E.coli phages 
infected all tested hosts, E.coli was only infected only by its phage. 
 
 
 
 
 
 
 
 
 
 
  Use of bacteriophages on the inactivation of pathogenic bacteria in aquaculture system 
 
 
Page | 60 
Table 3.4: Phage specificity to different bacteria. (+) Formation of phage plates and (-) No formation of phage plates 
 
 FISH PATHOGEN BACTERIAL 
Specific 
Phages 
Vibrio 
anguillarium 
Aeromonas 
salmonicida 
Photobacterium 
damselae  
damselae 
Photobacterium 
damselae  
piscicida 
Vibrio 
parahemoliticus E.coli 
Vibrio 
anguillarium 
Positive 
Control + + + + — 
Aeromonas 
salmonicida — 
Positive 
Control — — — — 
Photobacterium 
damselae 
damselae 
+ + 
Positive 
Control + + — 
Photobacterium 
damselae  
piscicida 
 
+ 
+ + 
Positive 
Control + — 
Vibrio 
parahemoliticus + + + + Positive Control — 
E.coli + + + + + Positive Control 
 
PHAGE SURVIVIAL DETERMINATION 
The results of the survival of the Aeromonas salmonicida and Vibrio parahemolyticus 
phages on marine water are represented in Figure 3.2 and 3.3. The pattern of phage survival was 
different for the two phages tested. The abundance of A. salmonicidae phages decreased by one 
order of magnitude in the first 15 days but, after reaching a plateau, that value was maintained 
up to 45 days. Afterwards, the phage titer decrease slightly up to 84 to 91 days. 
 
Figure 3.2: Survival of the specific phage for Aeromonas salmonicidae 
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Contrarily, the abundance of V. parahemoliticus phages decreased strongly during the 
incubation period, showing a survival period (12 to 16 days) much lower than the A. 
salmonicidae phage. 
 
Figure 3.3: Survival of the specific phage for Vibrio parahemoliticus 
PHAGE ADDITION EFFECTS ON THE BACTERIAL COMMUNITY STRUCTURE 
 
The effect of the addition of the specific phage of Aeromonas salmonicidae and of Vibrio 
parahemoliticus in the structural diversity of the bacterial community of the aquaculture can be 
observed in Figure 3.5 and Figure 3.6. Addition of the phages did not significantly alter the 
band profile, indicating that the addition of the specific phages of Aeromonas salmonicidae and 
of Vibrio parahemolyticus did not result in significant effects on the bacterial community 
structure. 
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Figure 3.4: DGGE profile of 16S rDNA after Aeromonas 
salmonicida phage addition to bacterial community of 
the aquaculture system. (M –Molecular weights marker, 
W-T0 – Water time zero; W-T20 - Water incubated during 
10 hours; F-100 – Water added of 100 µl Aeromonas 
salmonicida phage and incubated during 10 hours; TSB-
CL - Water added of chloroform and TSB medium). 
 
Figure 3.5: DGGE profile of 16S rDNA after Vibrio 
parahemolyticus phage addition to bacterial community 
of a aquaculture systems. (M –Molecular weights 
marker ;W-T0 – Water time zero; W-T10 - Water 
incubated during 10 hours; F-250µl – Water added of 
250µl Vibrio parahemolyticus phage and incubated 
during 10 hours; TSB-CL - Water added of chloroform 
and TSB medium). 
Bray-Curtis similarity index ranged between ~24% and ~93%, varying widely between 
samples. Cluster analysis of the band patterns obtained from DGGE analysis of the experiment 
with Aeromonas salmonicida phages (Figure 3.7) revealed the occurrence of two groups that 
included F-100, W-T20 and W-T0 and TSB-CL (control). Samples W-T0, W-T20 and TSB-CL 
were closely grouped (similarity > 80%), but were separated from TSB-CL (similarity 75%). 
 
 
 
Figure 3.7: Dendrogram generated from the pattern of bands obtained by DGGE (Figure 3.5). (W-T0 – Water time 
zero; W-T20 - Water aquaculture systems incubation during 10 hours; F-100 – Water and 100µl Aeromonas 
salmonicida phage incubation during 10 hours; TSB-CL - Water added of chloroform and TSB medium). 
Cluster analysis of the band patterns obtained from DGGE analysis of the experiment with 
Vibrio parahemolyticus phages (Figure 3.8) revealed the occurrence of two main groups, one 
including F-250, WT10  and TSB-CL (control) with a similarity > 92%, and the other include 
WT0 with a similarity > 86%. 
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Figure 3.8: Dendrogram generated from the pattern of bands obtained by DGGE (Figure 3.6). (WT0 – Water time 
zero; WT10 - Water aquaculture systems incubation during 10 hours; F250 – Water and 250µl Vibrio 
parahemolyticus phage incubation during 10 hours; TSBCL - Water added of chloroform and TSB medium). 
Discussion 
Fish contamination by pathogenic bacteria naturally present in the environment and by 
bacteria introduced through environmental contamination through domestic animals excreta 
and/or human wastes is a major problem on the expansion of aquaculture. As bacterial diseases 
are the major problem in the growing aquaculture industry, phage therapy represents a potential 
viable alternative to antibiotics and to other antimicrobial compounds to inactivate indigenous 
and non-indigenous pathogenic bacteria in fish farming plants. However, the success of phage 
therapy in aquaculture depends mainly on the phages selected to inactivate the fish pathogenic 
bacteria. The selected phages must remain viable in marine waters, infecting pathogenic bacteria 
but not altering significantly the non-pathogenic bacteria that have an important ecological role 
mainly in extensive and semi-intensive aquaculture regimes. The results of this study showed 
that phages of pathogenic bacteria can survive in marine water for up to three months, affecting 
a wide range of pathogenic bacteria without altering significantly the structure of the bacterial 
community. Unlike antibiotics, phages are self -replicating as well as self –limiting. They 
replicate exponentially as bacteria replicate and decline when bacterial numbers decrease. In 
this study it was possible to produce phages suspensions with high titers, up to 1010 PFU mL-1, 
suitable to use in phage therapy, that declined when bacteria were removed, but maintaining 
their high concentrations even after three months in marine water. This indicates that phages 
isolated in this study are well adapted to the aquatic environment, surviving for long periods in 
marine waters at in situ temperatures and, consequently, unlike antibiotics, a single phage done 
may be sufficient to inactivate bacteria in fish farming plants. 
Although it has been described that phages have specific targets, that is, they are 
specific to a single species or even strain of bacteria, causing less damage to the natural non-
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target bacteria, the results of this study show that the majority of the strain-specific phages can 
inactivate pathogenic bacteria from different families. Phages of indigenous bacteria are 
responsible for the majority of the outbreaks in fish farms. Photobacterium and Vibrio infect the 
host family but also bacteria of other families, such as Aeromonas. Similar results were obtained 
by Miller et al (2003) that isolated a broad-host-range vibriophage, KVP40, from sea water 
using Vibrio parahemolyticus 1010 (EB101) as the indicator host range of KVP40 extended 
over at least eight Vibrio sp and one Photobacterium sp. The phage of the non-indigenous 
bacterium Escherichia coli also infected the main fish pathogenic bacteria of the Vibrionaceae 
family and Aeromonas, but their host E. coli was not infected by five of the phages. However, 
the specific phage of the indigenous Aeromonas salmonicidae infected only its host, the agent of 
furunculosis. The phages of the Vibrionaceae bacteria and of E. coli can be used to inactivate a 
broad range of different fish infections, but the phages of Aeromonas salmonicida can only be 
used to treat the furunculosis. As the isolated bacteria display resistance to a broad range of 
antibiotics, namely Vibrio parahemolyticus, and are infect by at least one of the tested phages, 
phage therapy is a potentially viable alternative to antibiotics, inactivating even bacteria 
resistant to seven different antibiotics. 
Although the phages of Vibrio parahemolytius infect all the tested bacteria, they do not 
cause significant damage to the bacterial community structure. This fact suggests that Vibrio 
parahemolytius phages do not affect the non pathogenic bacteria, which are extremely important 
in extensive and semi-intensive aquaculture regimes, where part of the fish food results from 
organic matter transformed and /or produced by these bacteria.  
In conclusion, as the survival of pathogenic bacterial phages is high in marine water of 
aquaculture systems and these have a low ecological impact on the structure of the natural 
bacterial community of the aquaculture systems, phage therapy can be successfully applied to 
inactivate fish pathogenic bacteria. Moreover, the wide host range of these phages improves 
their potential to inactivate fish pathogenic bacteria. 
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Chapter 4 - Conclusions 
 
This work has been presented in four chapters that include preliminary studies in order to 
evaluate the suitability of phage therapy to treat bacterial infections on aquaculture systems, that 
were then analyzed based on the experiment results obtained. 
The main conclusions of this work are summarized in the following topics: 
 
• The analysis of the density of viral community in water column of the aquaculture system 
(6.10 x 109 - 1.09 x1010cells L-1), suggests that phage therapy can be a successful approach to 
inactive pathogenic bacteria. 
 
• The total bacterial number revealed to maintain almost constant over the year, but with a 
significant variance for the specific bacterial groups during the sampling period. 
 
• Enterobactereacea was the most abundant bacteria present in the aquaculture system. The 
presence of the indicators of faecal contamination during all the sampling period confirms the 
importance of the enteric bacterial group. This fact indicates that non-indigenous pathogenic 
bacteria are an important source of contamination in the aquaculture system. 
 
• Aeromonas and Vibrio genera also presented high concentrations in the aquaculture, showing 
that indigenous pathogenic bacteria are also an important source of contamination in the 
aquaculture system. 
 
• The high host range of the phages of Enterobacteriaceae, Aeromonas and Vibrio groups 
revealed that these phages could to be suitable for use in phage therapy treatments. 
 
• The diversity of the bacterial group that is responsible for the most fish farming plants 
outbreaks (Vibrio genus) varied seasonally, indicating that the monitoring of its seasonal 
variation should be done when selecting the specific phages to inactive fish pathogenic bacteria. 
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• The phages of the Vibrionaceae bacteria and of E.coli can be used to inactive a broad range 
of different fish infections, but the phages of Aeromonas salmonicida can be used only to treat 
the furunculosis. 
 
• Comparatively, the use of phages to inactive pathogenic bacteria instead of antibiotics bring 
many advantages such as the fact that phages are well adapted to the aquatic environment, 
surviving for long periods in marine waters at in situ temperatures and that a single phage dose 
may be sufficient to inactive bacteria in fish farming plants. 
 
• The addition of phages of Vibrio parahemolytius and Aeromonas salmonicida represents a 
low ecological impact on the structure of the natural bacterial community, which is extremely 
important in extensive and semi-intensive aquaculture regimes. 
 
 
As the survival of phages of pathogenic bacteria is high in marine water of aquaculture 
systems and these have a low ecological impact on the structure of the natural bacterial 
community of the aquaculture systems, phage therapy can be successfully applied to inactive 
fish pathogenic bacteria. Their wide host range is also an important fact that increases the 
potential of phage therapy to heal bacterial infections on aquaculture systems. 
